tyrosine has been researched along with Benign Neoplasms, Brain in 283 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 6 (2.12) | 18.7374 |
1990's | 13 (4.59) | 18.2507 |
2000's | 51 (18.02) | 29.6817 |
2010's | 158 (55.83) | 24.3611 |
2020's | 55 (19.43) | 2.80 |
Authors | Studies |
---|---|
Baučić, M; Golubić, AT; Hodolič, M; Huić, D; Mišir Krpan, A; Mrak, G; Nemir, J; Žuvić, M | 1 |
Cho, MS; Jang, Y; Kang, SY; Kim, BS; Kim, HO; Moon, BS; Park, SJ; Yoon, HJ | 1 |
McBean, R; Perkins, E; Tatkovic, A; Wong, D | 1 |
Blume, C; Clusmann, H; Delev, D; Galldiks, N; Hakvoort, K; Hamou, HA; Heiland, DH; Kernbach, JM; Langen, KJ; Lohmann, P; Mottaghy, FM; Neuloh, G; Ort, J | 1 |
Bauer, EK; Felsberg, J; Fink, GR; Galldiks, N; Kocher, M; Langen, KJ; Lohmann, P; Rapp, M; Rosen, J; Stoffels, G; Werner, JM; Wollring, M | 1 |
Buolamwini, JK; Deokar, H; Pfeffer, LM; Raje, M; Sacher, JR; Sims, MM; Turkson, J; Wang, Y; Yang, C; Yue, P | 1 |
Kang, SY; Kim, BS; Moon, BS; Yoo, MY; Yoon, HJ | 1 |
Anderson, JB; Choi, J; Daniels, DJ; Day, CA; Decker, PA; Ge, J; Hamdan, FH; Hinchcliffe, EH; Johnsen, SA; Kaptzan, T; Lu, VM; Nesvick, CL; Peterson, T; Power, EA; Siada, R; Simons, R; Welby, JP; Zhang, L | 1 |
Bauer, EK; Ceccon, G; Dunkl, V; Fink, GR; Galldiks, N; Goldbrunner, R; Heinzel, A; Herrlinger, U; Kabbasch, C; Langen, KJ; Rapp, M; Rosen, J; Ruge, M; Sabel, M; Schäfer, N; Stoffels, G; Tscherpel, C; Werner, JM | 1 |
Blok, M; Harat, M; Makarewicz, K; Małkowski, B; Miechowicz, I; Wiatrowska, I | 1 |
Doma, A; Skoblar Vidmar, M; Smrdel, U; Studen, A; Zevnik, K | 1 |
Allard, B; Ben Salem, D; Bourbonne, V; Dissaux, B; Dissaux, G; Keromnes, N; Latreche, A; Lepeuve, A; Mazouz Fatmi, D; Ognard, J; Querellou, S; Schick, U | 1 |
Bauer, EK; Ceccon, GS; Fink, GR; Galldiks, N; Goldbrunner, R; Kabbasch, C; Langen, KJ; Lohmann, P; Stoffels, G; Tscherpel, C; Werner, JM; Wollring, MM | 1 |
Albert, NL; Bartenstein, P; Bartos, LM; Herms, J; Holzgreve, A; Kaiser, L; Li, Z; Niyazi, M; Quach, S; Ruf, VC; Suchorska, B; Tonn, JC; Unterrainer, LM; Unterrainer, M; Wenter, V | 1 |
Albert, NL; Bartenstein, P; Bartos, LM; Brendel, M; Dekorsy, FJ; Herms, J; Holzgreve, A; Kaiser, L; Kirchleitner, SV; Nelwan, DV; Niyazi, M; Quach, S; Riemenschneider, MJ; Ruf, VC; Rupprecht, R; Stöcklein, S; Thon, N; Tonn, JC; Unterrainer, M; V Baumgarten, L; Weidner, L; Weller, J; Wetzel, C | 1 |
Combs, S; Gempt, J; Schlürmann, T; Waschulzik, B; Weber, W; Wiestler, B; Yakushev, I | 1 |
Detsky, J; Poon, R; Singnurkar, A | 1 |
Bison, B; Buck, AK; Dierks, A; Eyrich, M; Frühwald, MC; Kertels, O; Kircher, M; Krauß, J; Lapa, C; Mihovilovic, MI; Monoranu, CM; Pham, M; Samnick, S; Schlegel, PG | 1 |
Al Shughri, A; Brunn, A; Fink, GR; Galldiks, N; Kabbasch, C; Langen, KJ; Rosen, EK; Rueß, D; Ruge, MI; Stetter, I; Tscherpel, C; Werner, JM; Werr, L; Wollring, MM | 1 |
Fink, GR; Galldiks, N; Langen, KJ; Lohmann, P | 1 |
Joshi, RK; Kumar, A; Kumar, D; Kumar, P; Nagaraj, C; Thakur, R | 1 |
Adda, L; Back, M; Bailey, DL; Barnes, EH; Coffey, R; De Abreu Lourenco, R; Ebert, M; Fitt, G; Foroudi, F; Francis, RJ; Gan, HK; Hicks, RJ; Khasraw, M; Koh, ES; Lasocki, A; Lau, E; Lee, ST; Leonard, R; Moffat, BA; Moore, A; Nowak, AK; Roach, P; Rosenthal, M; Scott, AM; Senko, C; Thomas, PA; Verhaak, R; Walsh, KM | 1 |
Ceccon, G; Galldiks, N; Gutsche, R; Isensee, F; Kocher, M; Langen, KJ; Lohmann, P; Lowis, C; Régio Brambilla, C; Shah, NJ; Ziemons, K | 1 |
Borbély, K; Fedorcsák, I; Kenessey, I; Nagy, DG | 1 |
Brenner, W; Hamm, B; Lohmeier, J; Makowski, MR; Radbruch, H; Tietze, A | 1 |
Galldiks, N; Langen, KJ; Lohmann, P; Mottaghy, FM | 1 |
Cheresiz, S; Dyrkheeva, N; Kononova, A; Kovaleva, K; Lavrik, O; Mamontova, E; Oleshko, O; Pokrovsky, A; Salakhutdinov, N; Yarovaya, O; Zakharenko, A; Zakharova, O | 1 |
Cai, Q; Du, L; Jiang, BH; Jiang, T; Li, H; Li, X; Lorenzi, PL; Lu, Z; Qian, X; Shi, Z; Tan, L; Xia, Y; Xu, D; You, Y; Zhang, C; Zhao, D; Zheng, Y | 1 |
Bohner, G; Brenner, W; Hamm, B; Lohmeier, J; Makowski, MR; Siebert, E | 1 |
Andrée Larsen, V; Bashir, A; Broholm, H; Grunnet, K; Law, I; Mathilde Jacobsen, S; Mølby Henriksen, O; Møller, S; Skjøth-Rasmussen, J; Skovgaard Poulsen, H; Urup, T | 1 |
Antoch, G; Demircioglu, A; Forsting, M; Glas, M; Gratz, M; Griswold, M; Gulani, V; Haubold, J; Herrmann, K; Kannengiesser, S; Keyvani, K; Nensa, F; Nittka, M; Sure, U; Umutlu, L; Wrede, K | 1 |
Akhoundova, D; Andratschke, N; Bankel, L; Curioni-Fontecedro, A; Förster, R; Hiltbrunner, S; Hüllner, M; Kollias, S; Kraft, J; Lee, SY; Mader, C; Rushing, EJ; Schwanhäusser, B; Treyer, V | 1 |
Cabello, J; Eichinger, P; Gempt, J; Hock, A; Karimov, I; Keupp, J; Liesche-Starnecker, F; Metz, M; Meyer, B; Molina-Romero, M; Preibisch, C; Pyka, T; Schön, S; Weber, W; Wiestler, B; Yakushev, I; Zimmer, C | 1 |
Filss, CP; Fink, GR; Galldiks, N; Goldbrunner, R; Langen, KJ; Lohmann, P; Mottaghy, FM; Neumaier, B; Rapp, M; Sabel, M; Schmitz, AK; Shah, NJ; Stegmayr, C; Stoffels, G; Werner, JM | 1 |
Bauer, EK; Blau, T; Ceccon, G; Felsberg, J; Filss, CP; Fink, GR; Galldiks, N; Langen, KJ; Lohmann, P; Neumaier, B; Rapp, M; Reifenberger, G; Rosen, J; Sabel, M; Shah, NJ; Stoffels, G; Tscherpel, C; Werner, JM | 1 |
Bernstock, JD; Bhat, KP; Chagoya, G; Chiocca, EA; Elsayed, G; Estevez-Ordonez, D; Flanary, VL; Hackney, JR; Ilyas, A; Kim, SH; Kornblum, HI; Mohyeldin, A; Mooney, J; Nakano, I; Sadahiro, H; Yamaguchi, S; Yamashita, D; Zamboni, N | 1 |
Coenen, HH; Ermert, J; Filß, C; Galldiks, N; Heinzel, A; Langen, KJ; Lohmann, P; Mottaghy, FM; Stegmayr, C; Stoffels, G; Willuweit, A | 1 |
Esposito, G; Fischer, DR; Fuenfgeld, B; Huellner, MW; Kaufmann, PA; Mächler, P; Rushing, EJ; Stolzmann, P | 1 |
Ben Salem, D; Bourhis, D; Dissaux, B; Dissaux, G; Gujral, DM; Kabbaj, OE; Pradier, O; Querellou, S; Salaün, PY; Schick, U; Seizeur, R | 1 |
Nabavizadeh, SA; Nasrallah, IM; Pryma, DA | 1 |
Filss, CP; Galldiks, N; Langen, KJ; Lohmann, P; Stegmayr, C | 1 |
Aasen, T; Abdul Moin, NI; Abdul Wafi, S; Aboukameel, A; Abu-Bakar, N; Acharya, A; Ackermans, L; Adaramoye, O; Adarsh, KV; Adeosun, WA; Ahmad, NH; Ahmadi, F; Akanni, O; Akbar, M; Akbulak, RO; Akev, N; Akkaya, Ö; Al-Rashed, S; AlAbbad, S; Alabi, O; Alappat, BJ; Alcalá, S; Alcoutlabi, M; Aleppo, G; Alexander Ross, JB; Alexander, JH; Alexander, R; Alias, A; Alimba, C; Alken, FA; Allan, R; Alpers, M; Alsbou, EM; Amarasiri, SS; An, T; Anastasiadis, F; Anastassiadou, M; Anderson, KC; Andronikos, P; Anheyer, D; Annapurna, K; Anorlu, RI; Anten, MM; Anthopoulos, TD; Araujo-Castillo, RV; Aravamudhan, S; Arawwawala, LDAM; Arulsamy, N; Arunamata, A; Asghar, A; Asiri, AM; Aslanidou, T; Astrakhantseva, IV; Astutik, E; Attanayake, AP; Atwater, BD; Audureau, E; Augusto, S; Bakare, A; Banach, M; Bandelier, P; Banerjee, S; Barral, M; Bascuñán, J; Bates, FS; Bauer, NJC; Bayrak, BB; Beck, RW; Beckervordersantforth, J; Beeri, R; Begum, R; Beldi-Ferchiou, A; Bellingham, G; Ben-Tal, N; Bendib, I; Bergenstal, RM; Berger, MF; Bernasconi, G; Berry, S; Beuvon, F; Bi, WJ; Bi, Z; Bianconi, V; Bibi, I; Blank, BR; Bliemeister, E; Bobkowski, W; Bode, AM; Booth, CM; Bose, U; Boyd, K; Brancato, A; Brenmoehl, J; Brogi, E; Bronzo, P; Brooks, T; Brown, D; Brown, DN; Bruce, D; Buan, MEM; Bueno-Hernández, F; Bugielski, B; Bulavaitė, A; Buscagan, TM; Buxton, R; Caffaro, MM; Cai, Q; Cai, X; Cai, Y; Calhoun, P; Callander, N; Cambier, S; Camparo, P; Canales-Vargas, EJ; Canham, K; Cantu, J; Cao, J; Cao, JW; Cao, P; Cao, T; Cao, X; Caravella, BA; Carcadea, E; Carè, J; Carmichael, P; Carrasco Cabrera, L; Carteaux, G; Carvalho, PDS; Casarez, E; Cazorla, M; Celestrin, CP; Chakraborty, NK; Chan, B; Chandarlapaty, S; Chandgude, AL; Chang, CC; Chang, JH; Chang, X; Chang, Y; Chankhanittha, T; Chantanis, S; Chapovetsky, A; Chavan, S; Chen, B; Chen, D; Chen, F; Chen, G; Chen, H; Chen, J; Chen, K; Chen, KJ; Chen, KP; Chen, L; Chen, MA; Chen, Q; Chen, S; Chen, W; Chen, WF; Chen, X; Chen, Y; Cheng, D; Cheng, J; Cheng, Q; Cheon, GJ; Chiu, SC; Cho, CH; Cho, J; Choi, H; Choi, JS; Choi, YH; Christie, P; Chu, CH; Chu, Y; Chung, DH; Chung, F; Cline, JP; Cohen, A; Cohen, AD; Cohen, NJ; Comen, E; Compter, I; Cong, J; Cong, Z; Cooper, A; Cornud, F; Costa, C; Costa, S; Covey, A; Cowan, AM; Cramer, H; Cruz-Rivera, C; Cui, J; Cui, M; Cui, Y; Cui, YH; Culquichicón, C; Cushman, T; D'Auria, SJ; da Silva, J; Dalgediene, I; Danenberg, HD; Das, S; Dasgupta, K; Daubit, IM; de Oliveira, PD; de Prost, N; De Ruysscher, D; Dearman, K; Decato, D; Delfau-Larue, MH; Deng, L; Dhakate, SR; Dharuman, V; Di Costanzo, N; Dickler, MN; Dinehart, EE; Ding, D; Dinh, TK; Divya, KP; Djifack Tadongfack, T; Do, T; Domínguez-Roldan, R; Domínguez-Zambrano, E; Dömling, A; Donato, MD; Dong, JH; Dong, W; Dong, X; Dong, XR; Dong, Y; Dong, Z; Downs, M; Drutskaya, MS; Du, B; Du, F; Du, H; Du, L; Du, X; Duan, Z; Duangthip, D; Dunstand-Guzmán, E; Duong, F; Eckert, DJ; Edelhäuser, BAH; Eekers, DBP; Efendi, F; Efraimidis, P; Ehrenberg, H; Ehsanbakhsh, Z; Eickholt, C; Eksterowicz, J; El Mobadder, M; El-Araby, IE; El-Magd, MA; El-Tarabany, MS; Elgorban, AM; Engelmann, D; English, KL; Esfandiari, H; Eslami, B; Espinosa-Cuevas, A; Eswara, S; Faber, E; Fan, XH; Fan, Y; Fang, J; Fang, Z; Fantin, VR; Fei, P; Feng, G; Feng, H; Feng, J; Feng, X; Feng, XJ; Fennell, TR; Fernández-Moreira, V; Ferraz, ABF; Ferreras, KN; Flores, K; Flores-Pérez, I; Flox, C; Fluharty, FL; Fokouong Tchoffo, E; Folefack, GO; Foroutan, T; Fort, D; Fourati, S; Fousas, S; Frapard, T; Freguia, S; Friedman, DJ; Friedman, LS; Fu, D; Fu, Q; Fu, Y; Fujinami, S; Furihata, K; Gal, RL; Gan, H; Gao, C; Gao, F; Gao, R; Gao, SS; Gao, W; Gao, XC; Gao, Y; Gao, Z; Garozi, L; Ge, J; Georgiopoulos, A; Gerakiou, K; Ghazimirsaeed, SM; Ghazimirsaeed, ST; Gimeno, MC; Gjestad, R; Glurich, I; Goetchius, E; Goland, S; Goldstein, S; Gonçalves, CM; Gonçalves, H; Gong, Q; Gonzalez, D; Goplen, FK; Gorshkova, EN; Gotsman, I; Govindasamy, V; Granger, CB; Greco, L; Grigoriadou-Skouta, E; Grigoropoulos, P; Grivicich, I; Gromov, NV; Gruber, S; Grytczuk, M; Grzech-Leśniak, K; Gu, L; Gu, S; Gu, Z; Guadagnini, D; Guan, H; Guilliams, M; Guo, J; Guo, L; Gupta, A; Gupta, SK; Gurzu, S; Gutleb, AC; Haban, A; Hablitz, JJ; Hadisuyatmana, S; Hahn, S; Haiges, R; Hallal-Calleros, C; Hamed, M; Hammad, N; Hammer, N; Han, C; Hao, Y; Harnett, J; Has, EMM; Hassanpour, K; Hatzopoulos, D; Hawaldar, R; He, X; He, Y; He, YY; He, Z; Heberman, D; Heckl, D; Hegde, H; Henson, MA; Hernández-Velázquez, VM; Herrera, E; Hijazi, Z; Hirayama, K; Hirth, JM; Hoeben, A; Hohnloser, SH; Hong, M; Hood, K; Hoplock, LB; Hopman, WM; Horlbogen, LM; Hossein Rashidi, B; Hou, G; Hou, H; Hou, J; Hou, Y; Hu, J; Hu, W; Hu, X; Hua, W; Huang, G; Huang, H; Huang, J; Huang, T; Huang, W; Huang, Y; Huang, YD; Huang, Z; Hudis, CA; Hue, S; Huo, J; Hussain, M; Hvas, AM; Ichii, T; Ide Zeuna, J; Ilyas, S; Inoue, T; Iranzo, A; Irfan, M; Iwasa, Y; Iwashita, Y; Izgorodina, EI; J R, A; Jaber, WA; Jaborek, JR; Jacobus, SJ; Jadeja, SD; Jafarabadi, M; Jalan, D; Jamil, MI; Jarrah, S; Jarvis, D; Jayatilaka, KAPW; Jemal-Turki, A; Jeon, YK; Jeong, N; Jeong, SH; Jeong, SY; Jermy, M; Jhaveri, K; Ji, H; Ji, K; Ji, RY; Jiang, F; Jiang, J; Jiang, X; Jiang, Y; Jiao, Q; Jilani, K; Jiménez-Guerrero, P; Jin, L; Jo, YH; Johnson, JG; Johnson, ML; Jones, WS; Jose, S; Jularic, M; Jung, I; Jung, YJ; Jungen, C; Junttila, MR; Kache, S; Kahanovitch, U; Kalantzi, KI; Kallio, T; Kamnoedboon, P; Kang, CH; Kang, H; Kang, J; Kang, KW; Kapoor, P; Karmakar, D; Kartalis, A; Kauranen, P; Kazocina, A; Keikha, F; Keltai, M; Kershaw, SV; Kettani, M; Khalvati, S; Khandhar, S; Khosla, N; Kiely, CJ; Kim, CC; Kim, H; Kim, MJ; Kim, Y; Kim, YH; Kim, YT; Kimoto, E; Kiyu, A; Klatt, N; Kobayashi, M; Koh, J; Köhler, R; Kondadasula, SV; Kong, H; Kong, W; Kong, X; Kotidis, A; Kotwal, A; Kouvari, M; Kozhinov, AN; Kruger, D; Kuang, S; Kuang, Y; Kubota, M; Kuklik, P; Kumar, P; Kumar, SK; Kuo, YF; Kurup, SP; Kusuhara, H; Kuswanto, H; Lacouture, ME; Lambin, P; Lang, CC; Langroudi, FH; Lanman, RB; Larsen, OH; Laskin, J; Le, VH; Leach, M; Lee, BG; Lee, DF; Lee, DS; Lee, HJ; Lee, SB; Lee, YA; Lei, Y; Lekashvili, O; Lelj, F; Lemin, AS; Lemoine, J; Leuschner, R; Li, B; Li, BT; Li, C; Li, D; Li, F; Li, G; Li, H; Li, HW; Li, J; Li, M; Li, P; Li, Q; Li, S; Li, W; Li, X; Li, XY; Li, Y; Li, Z; Lian, Y; Liang, C; Liao, J; Liao, W; Liao, Y; Lin, D; Lin, W; Lin, YL; Lindbäck, J; Lindsay, AP; Ling, J; Linser, PJ; Liu, C; Liu, H; Liu, JJ; Liu, L; Liu, Q; Liu, SF; Liu, X; Liu, Y; Liu, Z; Liu, ZM; Lo Sterzo, C; Lo, ECM; Lobchuk, MM; Lodge, TP; Logotheti, S; Lonial, S; Lopes, G; Lopes, RD; Lopez, J; Lopez, SA; López-Santos, AL; López-Sendón, JL; Loring, Z; Louis, C; Lovita, AND; Lu, DZ; Lu, H; Lu, J; Lu, K; Lu, TT; Lu, Y; Luengo, A; Lum, LG; Luna, JM; Luo, L; Luo, R; Luo, T; Luo, X; Luo, Z; Lv, B; Lymperopoulos, N; Lyras, A; Lyu, Y; M Kannan, A; Ma, H; Ma, M; Ma, Q; Ma, S; Ma, WY; Ma, Y; Maalouf, E; Machado, FA; Maeda, K; Magrans, JO; Maharani, A; Maia, G; Mainwaring, RD; Maji, TK; Majumdar, K; Mannarino, MR; Mansuri, MS; Marinescu, SC; Markatos, G; Marquardt, S; Marraiki, N; Martens, C; Martínez, TJ; Marumo, K; Maruyama, H; Marwani, HM; Marzo, I; Masrati, G; Matamba, P; Mathialagan, S; Matys, J; Mayatra, JM; Mboua, PC; McArthur, T; McCrimmon, RJ; McIntosh, S; McSpadden, S; Medina-Campos, ON; Medvedovsky, AT; Mei, Z; Mekontso-Dessap, A; Menezes, AMB; Meng, J; Meng, P; Meng, Y; Menter, A; Mets, MB; Mets-Halgrimson, R; Metzger, T; Metzler-Nolte, N; Meyer, C; Mi, Y; Michailoviene, V; Mikrogeorgiou, A; Militz, H; Miller Iii, TF; Minarowska, A; Mir, S; Miron, I; Miyake, T; Moayer, F; Modi, S; Moeller, SJ; Mohamad, MN; Mohammed, EHM; Mokhonov, VV; Mondal, A; Moore, J; Moravcova, M; Mordi, IR; Mordi, NA; Mortensen, NP; Moscariello, C; Moser, J; Moynahan, ME; Mu, J; Mu, W; Mudduwa, LKB; Mukherjee, S; Mukhtar, A; Mulkey, DK; Murr, N; Mushtaq, Z; Muthuswamy, N; Mutlu, O; Muto, C; Myroforou, I; Na, KJ; Nabi, M; Nagornov, KO; Nagy, RJ; Naik, A; Nakajima, K; Nam, KT; Nam, YW; Namburath, M; Nammour, S; Namour, A; Namour, M; Nanan, S; Natsume, H; Nave, S; Naveed, A; Nazir, H; Ndubaku, C; Nedospasov, SA; Neradilek, MB; Newcomb, C; Nguépy Keubo, FR; Nguyen, M; Ning, J; Ning, Q; Noguchi, S; Nordahl, SHG; Nordfalk, KF; Norton, L; Noupoue, EM; Nouri, SS; Nowak, JK; Núñez, K; Oakes, K; Odegaard, JI; Ogorodnikova, OL; Ogunsuyi, O; Oh, HK; Oh, HR; Oh, KH; Ohgi, K; Okunade, KS; Oliveira, AG; Olorunfemi, G; Olsen, ML; Olson, BA; Omari, KW; Ondruschka, B; Orfali, R; Orkopoulos, A; Orlowski, RZ; Oser, SM; Oser, TK; Özcan, M; Padilla, V; Paeng, JC; Pajuelo-Lozano, N; Pal, SK; Palmieri, S; Palomeque, E; Pan, W; Panagiotakos, DB; Pandey, M; Pang, D; Pang, Q; Pangarah, CA; Panny, A; Paparella, A; Papirio, S; Papouskova, K; Parang, K; Park, HJ; Park, IK; Park, S; Parker, TL; Parkhomenko, A; Parmon, VN; Parsons, B; Parsons, J; Patel, PR; Patil, S; Patsourakos, NG; Patterson, KC; Pavlidis, P; Pedernera, M; Pedersen, R; Pedraza-Chaverri, J; Pellegrini, M; Peña-Chora, G; Pereira, EDM; Pereira, MADS; Peretz, A; Perez-Padilla, R; Perlman, GY; Perona, R; Petras, C; Phuntsho, S; Picada, JN; Pinder, TA; Piper, LFJ; Pirozzi, F; Pirro, M; Pleckaityte, M; Ploutz-Snyder, LL; Ploutz-Snyder, R; Pogorzelski, A; Poles, L; Postma, AA; Prager, A; Prakash, J; Punn, R; Pützer, BM; Qi, J; Qi, MC; Qi, Y; Qian, J; Qian, Y; Qiang, L; Qiu, J; Qu, Y; Rabiu, KA; Rahighi, S; Rahman, MM; Rahmani, B; Rajkumar, SV; Ramanathan, R; Raras, TYM; Rashi, Y; Rasool, G; Rathore, MG; Ratnawati, R; Ratola, N; Raucci, U; Ray, SK; Razavi, P; Razazi, K; Razek, S; Razi, SS; Reback, M; Reddy, K; Rees, DC; Reginatto, FH; Reich, H; Reis-Filho, JS; Ren, X; Ren, Y; Renner, G; Rey, G; Reymen, B; Riaz, M; Ricci, A; Richardson, PG; Richter, C; Riga, M; Ritchie, C; Rivoal, S; Roberts, W; Robson, ME; Rocha, GZ; Rodrigues, AD; Rogach, AL; Rojas, A; Rosenberg, A; Rosenberg, E; Rosenheck, RA; Roslan, K; Rothenberger, C; Rouschop, KMA; Rubagumya, F; Ryan, CM; Ryder, JW; Saad, MJA; Sacan, O; Sacchi, A; Sahebkar, A; Saini, A; Sainz, B; Sajo, EA; Sakizadeh, J; Saleh, AA; Salgado Júnior, IB; Salvi, R; Samoylova, YV; Samuni, A; Sanchez, DM; Sanchez-Perez, I; Santos, M; Sarapulova, A; Sardot, T; Saud, N; Sauerbier, P; Scaltriti, M; Schaeffer, B; Schalk, DL; Scherschel, K; Schijven, MP; Schreuder, HWR; Schuhmacher, M; Schultz-Lebahn, A; Schwarzl, J; Scott, JM; Sebayang, SK; Seeger, ZL; Segabinazi Peserico, C; Selenica, P; Serio, A; Seruga, B; Shah, A; Shah, C; Shah, PD; Shahrokh Tehraninezhad, E; Shan, A; Shao, Z; Sharma, AMR; Sharma, RK; Shen, J; Shen, R; Shi, X; Shi, Y; Shi, ZE; Shih, YC; Shimohata, H; Shimpi, N; Shin, SH; Shon, HK; Shuvy, M; Siddique, AB; Siegbahn, A; Sikandar, M; Silvani, Y; Singh, A; Singh, AK; Singh, D; Singh, JS; Singh, KP; Singh, M; Situ, B; Skipper, MT; Skouloudi, M; Sloane, BF; Smyrnioudis, N; Snyder, MA; Söhnchen, C; Solis Condor, R; Solit, DB; Someya, S; Song, H; Song, J; Song, W; Song, Y; Sorokina, KN; Soshi, S; Soyer, P; Spitschak, A; Sreekrishnan, TR; Srinivasan, M; Staruschenko, A; Steel, A; Stefan-van Staden, RI; Stein, AM; Strayer, H; Struthers, AD; Su, H; Su, Q; Su, X; Sudore, RL; Sugimura, H; Sugiyama, Y; Sujuti, H; Sumner, SJ; Sun, B; Sun, D; Sun, H; Sun, J; Sun, JY; Sun, X; Sun, Y; Sun, Z; Sung, YC; Surenaud, M; Sutimantanapi, D; Suwandaratne, NS; Swaroop, S; Sychrova, H; Syed, A; Szczepanik, M; Szederjesi, J; Szodorai, R; Tacy, TA; Tadelle, RM; Takayasu, M; Tammeveski, K; Tan, H; Tan, M; Tang, HX; Tang, S; Tang, X; Tanokura, M; Tao, F; Tao, H; Tarafdari, A; Tarín-Carrasco, P; Tasson Tatang, C; Teixeira, JP; Thakur, A; Theobald, A; Thevenot, P; Thomaidis, K; Tian, J; Tillib, SV; Toma, C; Tomita, M; Tonchev, I; Tong, F; Toy, W; Trypuć, M; Tselepis, AD; Tsetseris, L; Tsikouri, GE; Tsikouris, EI; Tsoplifack, CB; Tsoumani, ME; Tsujimoto, R; Tsybin, YO; Tu, J; Tu, TM; Turco, M; Turkyilmaz, IB; Uddin, MJ; Ung, J; Unsihuay, D; Utsunomiya, T; Vagenende, B; Vaishnav, J; Valdes, C; Validad, MH; Valle, J; van Ginkel, MPH; van Grevenstein, WMU; Vanderpuye, V; Vasan, N; Vasilenko, EA; Vasques, GJ; Vavoulis, P; Verani, A; Veziroglu, E; Viegas, A; Vitali, MG; Vitsas, G; Voccio, JP; Vogiatzidis, C; Volow, A; Volpin, F; Vourvahis, M; Wagner, LI; Walkowiak, J; Wallace, R; Wallentin, L; Wan, D; Wan, L; Wan, T; Wang, C; Wang, F; Wang, FN; Wang, H; Wang, J; Wang, L; Wang, Q; Wang, S; Wang, T; Wang, W; Wang, X; Wang, XW; Wang, Y; Wang, YS; Wang, Z; Ward, J; Ward, L; Waseem, R; Watson, DF; Weber, P; Wehrmeister, FC; Wei, CH; Wei, H; Wei, L; Wei, Q; Wei, Y; Weinstock, RS; Weiss, M; Welborn, M; Wen, L; Wen, LM; Wen, Q; Wen, Z; Wesseling, P; Westerbergh, J; White, K; Wick, MP; Willems, S; Wiyasa, IWA; Wójciak, R; Wolkenhauer, O; Won, HH; Wong, J; Woo, YC; Wood, LS; Wu, CT; Wu, CY; Wu, D; Wu, G; Wu, J; Wu, K; Wu, M; Wu, Q; Wu, T; Wu, W; Wu, X; Wu, XT; Wu, Y; Xi, D; Xi, J; Xiang, W; Xiang, Y; Xiao, M; Xiao, Z; Xie, H; Xie, Q; Xie, S; Xie, X; Xing, M; Xing, YL; Xu, C; Xu, X; Xu, Y; Xu, Z; Xue, F; Xue, XD; Yaglioglu, HG; Yamada, H; Yamashita, M; Yan, W; Yan, Z; Yanardag, R; Yang, D; Yang, H; Yang, K; Yang, QQ; Yang, R; Yang, S; Yang, T; Yang, X; Yang, Y; Yao, H; Yao, Y; Yari, D; Yassin, MT; Ye, C; Ye, J; Ye, Q; Yildiz, EA; Ying, S; Yoon, H; Yu, D; Yu, K; Yu, N; Yu, PL; Yuan, C; Yuan, D; Yuan, LJ; Yuan, Z; Yuen, N; Zagatto, AM; Zakaria, Y; Zalewski, AM; Zamora, S; Zavorotinskaya, T; Zeid, JL; Zeinoun, T; Zeng, C; Zerby, HN; Zhan, X; Zhang, A; Zhang, D; Zhang, E; Zhang, F; Zhang, H; Zhang, J; Zhang, L; Zhang, M; Zhang, P; Zhang, Q; Zhang, QY; Zhang, RG; Zhang, S; Zhang, T; Zhang, X; Zhang, Y; Zhang, YY; Zhao, CK; Zhao, H; Zhao, J; Zhao, K; Zhao, Q; Zhao, S; Zhao, T; Zhao, XQ; Zhao, Y; Zhao, Z; Zheng, J; Zheng, L; Zheng, Y; Zhou, B; Zhou, G; Zhou, L; Zhou, T; Zhou, X; Zhu, C; Zhu, J; Zhu, Y; Zhu, ZQ; Zhuang, T; Zimmermannova, O; Zin, NNINM; Zisimos, K; Zoghebi, KA; Zonder, JA; Zou, C; Zwirner, J | 1 |
Abdulla, DSY; Baues, C; Ceccon, G; Celik, E; Fink, GR; Galldiks, N; Hüllner, M; Kocher, M; Kreuzberg, N; Landsberg, J; Langen, KJ; Lohmann, P; Marnitz, S; Mauch, C; Ruge, MI; Scheffler, M; Schlaak, M; Schweinsberg, V; Stoffels, G; Tonn, JC; Trommer, M; Weller, M; Werner, JM; Wolf, J; Wolpert, F | 1 |
Caparrotti, F; Conen, K; Hottinger, AF; Hundsberger, T; Ochsenbein, A; Remonda, L; Roelcke, U; Roth, P; Tabatabai, G; von Moos, R; Weller, J; Weller, M; Wirsching, HG | 1 |
Albert, NL; Bartenstein, P; Belka, C; Fleischmann, DF; Forbrig, R; Herms, J; Niyazi, M; Ruf, V; Rupprecht, R; Tonn, JC; Unterrainer, M; Vettermann, FJ | 1 |
Filipski, K; Filss, CP; Galldiks, N; Hattingen, E; Hmeidan, SA; Keil, F; Langen, KJ; Lohmann, P; Maurer, GD; Mottaghy, FM; Polomac, N; Shah, NJ; Steidl, E; Steinbach, JP | 1 |
Antoch, G; Bundschuh, RA; Colletti, PM; Forsting, M; Glas, M; Herrlinger, U; Herrmann, K; Kebir, S; Keyvani, K; Kleinschnitz, C; Lazaridis, L; Milia, A; Pierscianek, D; Rauschenbach, L; Rubello, D; Schäfer, N; Scheffler, B; Schmidt, T; Stuschke, M; Sure, U; Umutlu, L; Weber, M | 1 |
Brenner, W; Driever, PH; Grosse, F; Koch, A; Plotkin, M; Steffen, I; Thomale, UW; Wedel, F | 1 |
Brambilla, CR; Caldeira, L; Galldiks, N; Herzog, H; Jon Shah, N; Kops, ER; Langen, KJ; Lerche, CW; Lohmann, P; Radomski, T; Scheins, J; Tellmann, L | 1 |
Bourhis, D; Dissaux, B; Dissaux, G; Querellou, S; Schick, U | 1 |
Bello-Alvarez, C; Camacho-Arroyo, I; González-Arenas, A; Moral-Morales, AD | 1 |
Borgwardt, L; Broholm, H; Forman, JL; Henriksen, OM; Højgaard, L; Law, I; Lundemann, M; Marner, L; Mathiasen, R; Nysom, K; Sehested, A; Skjøth-Rasmussen, J; Thomsen, C; Wehner, PS; Østrup, O | 1 |
Blauensteiner, K; Calabek-Wohinz, B; Freydl, E; Hainz, K; Heinz, G; Marhold, F; Minear, G; Oberndorfer, S; Tesar-Pelz, M; Tinchon, A | 1 |
Bauer, EK; Baues, C; Ceccon, G; Celik, E; Fink, GR; Galldiks, N; Gielen, GH; Herrlinger, U; Kabbasch, C; Langen, KJ; Lohmann, P; Marnitz, S; Schäfer, N; Schaub, C; Stoffels, G; Tscherpel, C; Weller, J; Werner, JM | 1 |
Byun, BH; Chi, DY; Choi, CW; Kil, HS; Kim, BI; Lee, KC; Lim, I; Lim, SM; Moon, H; Park, C; Rhee, CH; Woo, SK; Youn, SM | 1 |
Black, D; Kaneko, S; Schipmann, S; Sporns, P; Stummer, W; Suero Molina, E | 1 |
Berkmann, S; Christ-Crain, M; Juengling, F; Mariani, L; Mueller, B; Nitzsche, E; Roethlisberger, M | 1 |
Filss, C; Galldiks, N; Heinzel, A; Langen, KJ; Lohmann, P; Mottaghy, FM; Neumaier, B; Stegmayr, C; Stoffels, G; Willuweit, A | 1 |
Fouquet, JP; Lebel, R; Lepage, M; Richard, MA | 1 |
Langen, KJ; Loução, R; Oros-Peusquens, AM; Shah, NJ; Zimmermann, M | 1 |
Back, M; Bailey, D; Brazier, D; Chan, D; Jaymanne, DT; Kaushal, S; Schembri, G; Wheeler, H | 1 |
Albert, NL; Bartenstein, P; Biczok, A; Drexler, M; Giese, A; Schüller, U; Suchorska, B; Tonn, JC; Unterrainer, M; Weller, M | 1 |
Bumes, E; Galldiks, N; Grosse, J; Hau, P; Hellwig, D; Hutterer, M; Langen, KJ; Riemenschneider, MJ | 1 |
Eickhoff, SB; Fink, GR; Galldiks, N; Guedj, E; Langen, KJ; Lohmann, P; Shah, NJ; Stegmayr, C; Stoffels, G; Van Der Gucht, A; Verger, A | 1 |
Giovanella, L; Muoio, B; Treglia, G | 1 |
Atwa, ST; Eltaoudy, MH; Omar, WM; Shama, SA; Siddiq, IS | 1 |
Choi, CH; da Silva, NA; Fairney, J; Galldiks, N; Golay, X; Jon Shah, N; Langen, KJ; Lohmann, P; Magill, AW; Oros Peusquens, AM; Stirnberg, R; Stoffels, G | 1 |
Blau, T; Ceccon, G; Fink, GR; Galldiks, N; Glas, M; Herrmann, K; Kebir, S; Langen, KJ; Lazaridis, L; Lohmann, P; Rapp, M; Stoffels, G; Weber, M | 1 |
Bashir, A; Brennum, J; Broholm, H; Law, I | 1 |
Gao, L; Liang, F; Tao, L; Weng, J; Xu, W; Yu, J; Zhang, J; Zheng, J | 1 |
Buck, AK; Ernestus, RI; Hänscheid, H; Kertels, O; Kessler, AF; Kleinlein, I; Lapa, C; Linsenmann, T; Löhr, M; Mihovilovic, MI; Monoranu, CM; Samnick, S | 1 |
Gielen, GH; Giordano, FA; Glas, M; Herrlinger, U; Kebir, S; Lazaridis, L; Rauschenbach, L; Schäfer, N; Scheffler, B; Tzaridis, T | 1 |
Bartek, J; Daxberg, EL; Förander, P; Gempt, J; Jakola, AS; Laesser, M; Liljegren, A; Näslund, O; Smits, A | 1 |
Gempt, J; Hiob, D; Preibisch, C; Pyka, T; Schlegel, J; Straube, C; Wiestler, B; Zimmer, C | 1 |
Amunts, K; Galldiks, N; Geisler, S; Langen, KJ; Lohmann, P; Mohlberg, H; Oros-Peusquens, AM; Piroth, MD; Sellhaus, B; Shah, NJ; Weis, J | 1 |
Allinson, K; Bielik, R; Booth, T; Brindle, KM; Jones, J; Lewis, DY; Lyons, SK; Mair, R; Soloviev, D; Wright, A | 1 |
Bauer, EK; Ceccon, G; Fink, GR; Galldiks, N; Kocher, M; Langen, KJ; Lohmann, P; Neumaier, B; Ruge, MI; Shah, NJ; Stoffels, G; Viswanathan, S | 1 |
Albert, NL; Bartenstein, P; Diekmann, C; Dorostkar, M; Kümpfel, T; Tonn, JC; Unterrainer, M; Vettermann, FJ | 1 |
Bock, M; Bott, S; Grosu, AL; Mader, I; Meyer, PT; Mix, M; Nestle, U; Nieder, C; Oehlke, O; Popp, I; Schimek-Jasch, T; Urbach, H; Weber, WA; Yuh, WTC | 1 |
Buchmann, N; Gempt, J; Kirschke, JS; Meyer, B; Pyka, T; Ringel, F; Ryang, YM | 1 |
Abdollahi, A; Afshar-Oromieh, A; Debus, C; Debus, J; Floca, R; Haberkorn, U; Ingrisch, M; Knoll, M | 1 |
Cook, R; Ibbett, I; Parkinson, J; Schembri, G | 1 |
Bauer, EK; Ceccon, G; Fink, GR; Galldiks, N; Langen, KJ; Lipke, K; Lohmann, P; Neumaier, B; Shah, NJ; Stavrinou, P; Werner, JM | 1 |
Belanger, AP; Dubey, S; George, E; Horky, L; Huang, RY; Kesari, S; Kijewski, MF; Park, MA; Reardon, DA; Wen, PY | 1 |
Albert, NL; Berding, G; Felsberg, J; Forbrig, R; Galldiks, N; Hasselblatt, M; la Fougère, C; Reifenberger, G; Schittenhelm, J; Schüller, U; Vettermann, FJ; Weis, J | 1 |
Chen, TC; Markland, FS; Minea, RO; Swenson, S; Thein, TZ; Tuan, CD | 1 |
Engelholm, S; Engelholm, SA; Grunnet, K; Law, I; Lundemann, MJ; Muhic, A; Munck Af Rosenschold, P; Roed, H; Skovgaard Poulsen, H | 1 |
Abdulla, DSY; Brandes, V; Büttner, R; Drzezga, A; Fischer, R; Galldiks, N; Grau, S; Kobe, C; Kunze, S; Merkelbach-Bruse, S; Michels, S; Nogova, L; Persigehl, T; Riedel, R; Ruge, M; Scheffler, M; Wolf, J | 1 |
Langen, KJ; Lohmann, P; Stegmayr, C; Willuweit, A | 1 |
Bellu, L; Bertin, D; Caccese, M; Cuppari, L; Evangelista, L; Lombardi, G; Reccia, P; Zagonel, V | 1 |
Buchmann, N; Gempt, J | 1 |
Benitez, JA; Boyer, A; Cavenee, WK; Chen, CC; DeGroot, J; Fenton, TR; Furnari, FB; Gahman, TC; Galatro, T; Koga, T; Kolodner, RD; Li, J; Lindahl, E; Ma, J; Miki, S; Nagahashi Marie, SK; Orellana, L; Ponte de Albuquerque, C; Reed, R; Shiau, AK; Sulman, EP; Varki, NM; Zanca, C; Zhou, H | 1 |
Duan, H; Fang, X; Kong, W; Qiu, J; Yu, Z | 1 |
Alberts, E; Angelikopoulos, P; Combs, SE; Diehl, C; Hadjidoukas, P; Koumoutsakos, P; Lipkova, J; Lowengrub, J; Menze, B; Preibisch, C; Pyka, T; Van Leemput, K; Wiestler, B; Wu, S | 1 |
Brändlein, S; Buck, AK; Ernestus, RI; Kertels, O; Kessler, AF; Lapa, C; Linsenmann, T; Löhr, M; Mihovilovic, MI; Monoranu, CM; Samnick, S; Stolzenburg, A | 1 |
Galldiks, N; Langen, KJ; Lindemeyer, J; Lohmann, P; Neumaier, B; Shah, NJ; Shymanskaya, A; Stoffels, G; Worthoff, WA | 1 |
Albert, NL; Bartenstein, P; Dunkl, V; Fink, GR; Galldiks, N; Judov, N; Kreth, FW; Langen, KJ; Lohmann, P; Rapp, M; Stoffels, G; Suchorska, B; Tonn, JC; Unterrainer, M; Vettermann, F | 1 |
Boellaard, R; De Witt Hamer, PC; Hoekstra, OS; Koopman, T; Lammertsma, AA; Pouwels, PJ; Verburg, N; Wesseling, P; Yaqub, M | 1 |
Bolcaen, J; Boterberg, T; De Meulenaere, V; De Vos, F; Deblaere, K; Descamps, B; Donche, S; Goethals, I; Kalala, JP; Kersemans, K; Van den Broecke, C; Vanhove, C; Verhoeven, J | 1 |
Alexiou, GA; Fotopoulos, AD; Jabbour, P; Katsanos, AH; Kyritsis, AP; Sioka, C | 1 |
Koch, R; Müther, M; Schwindt, W; Sporns, P; Stummer, W; Weckesser, M | 1 |
Brumberg, J; Ernestus, RI; Kertels, O; Kessler, AF; Kircher, M; Lapa, C; Linsenmann, T; Löhr, M; Meyer, PT; Mihovilovic, MI; Monoranu, CM; Samnick, S; Tran-Gia, J | 1 |
Kamson, DO | 1 |
Albert, NL; Bartenstein, P; Belka, C; Corradini, S; Fleischmann, DF; Förster, S; la Fougère, C; Niyazi, M; Rottler, M; Schwaiger, M; Siepmann, T; Unterrainer, M | 1 |
Brunn, A; Fink, GR; Galldiks, N; Langen, KJ | 1 |
Pichler, R | 1 |
Engelbach, JA; Garbow, JR; Huang, C; Mach, RH; McConathy, J; Piwnica-Worms, D; Rich, KM; Sai, KK; Yuan, L; Zhou, D | 1 |
Galldiks, N; Langen, KJ | 1 |
Langen, KJ | 1 |
Coenen, HH; Eble, MJ; Geisler, S; Langen, KJ; Piroth, MD; Prasath, J; Sellhaus, B; Shah, NJ; Stoffels, G; van Osterhout, A; Willuweit, A | 1 |
Blaum, M; Galldiks, N; Heinzel, A; Langen, KJ; Mottaghy, FM; Müller, D; Verburg, FA | 1 |
Fougère, Cl; Hutterer, M; Jacobs, AH; Nowosielski, M; Putzer, D; Stockhammer, G; Virgolini, IJ | 1 |
Burger, U; Combs, SE; Debus, J; Giesel, FL; Haberkorn, U; Habermehl, D; Hoffmann, C; Rief, H; Rieken, S; Welzel, T | 1 |
De Souza, PC; Ehrenshaft, M; Gomez-Mejiba, SE; Henry, L; Lupu, F; Mason, RP; Ramirez, DC; Saunders, D; Silasi-Mansat, R; Smith, N; Towner, RA | 1 |
Coenen, HH; Eble, MJ; Galldiks, N; Langen, KJ; Liebenstund, S; Piroth, MD; Shah, NJ; Stoffels, G | 1 |
Kung, HF; Lieberman, BP; Ploessl, K; Wang, L | 1 |
Kawada, T | 1 |
Floeth, FW; Galldiks, N; Langen, KJ; Rapp, M; Reifenberger, G | 1 |
Coenen, HH; Filss, C; Galldiks, N; Herzog, H; Langen, KJ; Neuner, I; Rota Kops, E; Shah, NJ; Stoffels, G; Tellmann, L; Zhang, K | 1 |
Flentje, M; Polat, B; Reiners, C; Samnick, S; Sweeney, R; Verburg, FA | 1 |
Afshar-Oromieh, A; Combs, SE; Debus, J; Giesel, FL; Haberkorn, U; Kratochwil, C; Leotta, K; Rieken, S | 1 |
Bartenstein, P; Drexler, M; Eigenbrod, S; Jansen, NL; Kreth, FW; la Fougère, C; Niyazi, M; Schmid-Tannwald, C; Schnell, O; Suchorska, B; Thon, N; Tonn, JC; Wenter, V; Zwergal, A | 1 |
Berberat, J; Boxheimer, L; Bruehlmeier, M; Nitzsche, EU; Rahm, V; Remonda, L; Roelcke, U | 1 |
Chen, JH; Huang, SS; Lin, C; Lu, DY; Tsai, CF; Yeh, WL | 1 |
Förschler, A; Förster, S; Gempt, J; Grams, AE; Meyer, B; Ringel, F; Ryang, YM; Schlegel, J; Soehngen, E; Zimmer, C | 1 |
Bloch, J; Dunet, V; Lhermitte, B; Maeder, P; Meuli, R; Nicod-Lalonde, M; Pollo, C; Prior, JO; Stupp, R | 1 |
Donnola, S; Eswarappa, SM; Fan, Y; Fox, PL; Gong, Y; Hambardzumyan, D; Lathia, JD; Potdar, AA; Rich, JN | 1 |
Kjaer, A; Kristoffersen, K; Lassen, U; Madsen, J; Michaelsen, SR; Nedergaard, MK; Poulsen, HS; Stockhausen, MT | 1 |
Förster, S; Gempt, J; Hüttinger, S; Nekolla, S; Pyka, T; Ringel, F; Schwaiger, M; van Marwick, S; Wester, HJ | 1 |
Bilger, A; Bittner, MI; Firat, E; Grosu, AL; Meyer, PT; Milanović, D; Niedermann, G; Weber, WA; Wiedenmann, N | 1 |
Bluemel, C; Buck, AK; Czernin, J; Ernestus, RI; Herrmann, K; Homola, GA; Kessler, AF; Lapa, C; Linsenmann, T; Löhr, M; Monoranu, CM; Samnick, S | 1 |
Bolcaen, J; Boterberg, T; De Vos Pharm, F; Deblaere, K; Decrock, E; Descamps, B; Goethals, I; Kalala, JP; Leybaert, L; Van den Broecke, C; Vanhove, C | 1 |
Driever, PH; Grosse, F; Guggemos, A; Koch, A; Misch, M; Plotkin, M; Steffen, IG; Thomale, UW | 1 |
Blau, T; Dorn, F; Drzezga, A; Dunkl, V; Fink, GR; Galldiks, N; Goldbrunner, R; Hau, P; Herrlinger, U; Hutterer, M; Kebir, S; Kocher, M; Langen, KJ; Rapp, M; Reifenberger, G; Ruge, MI; Sabel, M; Schmidt, M; Stoffels, G | 1 |
Andersen, SB; Bøgeskov, L; Cleff, C; Coenen, HH; Dunkl, V; Fink, GR; Galldiks, N; Judov, N; Langen, KJ; Law, I; Nysom, K; Reifenberger, G; Sarikaya-Seiwert, S; Shah, NJ; Steiger, HJ; Stoffels, G | 1 |
Costa, J; Engelholm, S; Engelholm, SA; Law, I; Lundemann, MJ; Munck Af Rosenschold, P; Ohlhues, L | 1 |
Eigenbrod, S; Jansen, NL; Janssen, H; Kreth, FW; Kretzschmar, H; la Fougere, C; Linn, J; Pöpperl, G; Simon, M; Suchorska, B; Tonn, JC; Weller, M | 1 |
Broholm, H; El Ali, H; Kjaer, A; Lassen, U; Michaelsen, SR; Nedergaard, MK; Poulsen, HS; Stockhausen, MT; Urup, T | 1 |
Bette, S; Buchmann, N; Förster, S; Gempt, J; Meyer, B; Peschke, P; Pyka, T; Ringel, F; Ryang, YM; Wester, HJ | 1 |
Coenen, HH; Filss, C; Galldiks, N; Herzog, H; Judov, N; Langen, KJ; Lohmann, P; Rota Kops, E; Sabel, M; Shah, NJ; Stoffels, G; Tellmann, L; Weiss, C | 1 |
Blau, T; Ceccon, G; Dunkl, V; Filss, C; Fink, GR; Galldiks, N; Langen, KJ; Rapp, M; Sabel, M; Shah, NJ; Stoffel, M; Stoffels, G; Tscherpel, C; Weinzierl, M | 1 |
de Nijs, R; Dyssegaard, A; Feng, L; Fischer, W; Guilloteau, D; Jensen, P; Knudsen, GM; Larsen, VA; Law, I; Mikkelsen, JD; Pinborg, LH; Svarer, C; Thomsen, G | 1 |
Bette, S; Förster, S; Gempt, J; Hiob, D; Meyer, B; Pyka, T; Ringel, F; Schlegel, J; Wester, HJ | 1 |
Bette, S; Buchmann, N; Förschler, A; Förster, S; Gempt, J; Meyer, B; Pyka, T; Ringel, F; Ryang, YM; Wester, HJ | 1 |
Hansen, AE; Henriksen, OM; Larsen, VA; Larsson, HBW; Law, I; Muhic, A; Poulsen, HS | 1 |
Ewelt, C; Hasselblatt, M; Holling, M; Jaber, M; Niederstadt, T; Stummer, W; Weckesser, M; Wölfer, J; Zoubi, T | 1 |
Desiderio, DM; Guo, T; Li, J; Li, M; Li, X; Peng, F; Sang, S; Yang, H; Zhan, X | 1 |
Coenen, HH; Filss, C; Galldiks, N; Langen, KJ; Oliveira, D; Schöneck, M; Shah, NJ; Stegmayr, C; Willuweit, A | 1 |
Fimmers, R; Galldiks, N; Glas, M; Herrlinger, U; Kebir, S; Langen, KJ; Mack, F; Niessen, M; Schäfer, N; Schaub, C; Scheffler, B; Simon, M; Stoffels, G; Stuplich, M; Tzaridis, T | 1 |
Bette, S; Delbridge, C; Foerster, S; Gempt, J; Huber, T; Kirschke, JS; Meyer, B; Pyka, T; Ringel, F; Schlegel, J; Zimmer, C | 1 |
Bacher-Stier, C; Berndt, M; Bullich, S; Chin, FT; Dinkelborg, LM; Fels, LM; Friebe, M; Gambhir, SS; Gekeler, V; Hoehne, A; Iagaru, AH; Keu, KV; Koglin, N; Kumar, M; Mittra, ES; Moon, DH; Mosci, C; Mueller, A; Schmitt-Willich, H; Stephens, AW | 1 |
Bauer, JS; Buchmann, N; Delbridge, C; Gempt, J; Kläsner, B; Krause, BJ; Meyer, B; Pyka, T; Ringel, F | 1 |
Erler, J; Kjaer, A; Lassen, U; Michaelsen, SR; Nedergaard, MK; Perryman, L; Poulsen, HS; Stockhausen, MT | 1 |
Alyami, W; Bouhlel, A; Li, A; McConathy, J; Rich, K; Yuan, L | 1 |
Andratschke, N; Brown, M; Gulden-Sala, W; Roth, P; Stupp, R; Weller, M | 1 |
Albert, NL; Bartenstein, P; Fendler, WP; Schmid-Tannwald, C; Schüller, U; Schweisthal, F; Suchorska, B; Tonn, JC; Unterrainer, M; Wenter, V | 1 |
Dunet, V; Prior, JO | 1 |
Bai, H; Huang, X; Tang, H; Yang, L; Zhou, H | 1 |
Domínguez-Prieto, M; González-Sánchez, A; Herrero-González, S; Jaraíz-Rodríguez, M; Medina, JM; Tabernero, A | 1 |
Ackermann, U; Burvenich, IJ; Gan, HK; Gong, S; Guo, N; Kocovski, P; Lee, FT; Liu, Z; O'Keefe, GJ; Rigopoulos, A; Scott, AM; Tochon-Danguy, H | 1 |
Ebner, Y; Egger, B; Fritsch, B; Galldiks, N; Grosse, J; Hau, P; Hellwig, D; Hutterer, M; Langen, KJ; McCoy, M; Menhart, K; Meyer, PT; Proescholdt, M; Riemenschneider, MJ; Roelcke, U; Schröder, M; Stockhammer, G; Trinka, E; Urbach, H; Wendl, C; Willuweit, A | 1 |
Bauer, E; Ceccon, G; Filss, CP; Fink, GR; Galldiks, N; Hamisch, C; Judov, N; Kocher, M; Kuchelmeister, K; Langen, KJ; Lohmann, P; Rapp, M; Ruge, MI; Sabel, M; Sellhaus, B; Shah, NJ; Stoffels, G | 1 |
Kameyama, M; Umeda-Kameyama, Y | 1 |
Af Rosenschöld, PM; Christensen, IJ; Grunnet, K; Jensen, ML; Larsen, VA; Law, I; Poulsen, HS; Poulsen, SH; Urup, T | 1 |
Bundschuh, RA; Galldiks, N; Glas, M; Hattingen, E; Herrlinger, U; Kebir, S; Landsberg, J; Langen, KJ; Rauschenbach, L; Scheffler, B; Schlaak, M | 1 |
Costa, J; Engelholm, S; Engelholm, SA; Law, I; Moller, S; Munck Af Rosenschold, P; Poulsen, HS | 1 |
Cai, H; Guastella, AR; Juhász, C; Klinger, NV; Mangner, TJ; Michelhaugh, SK; Mittal, S; Muzik, O; Polin, LA; Xin, Y; Zhang, S | 1 |
Albert, NL; Bartenstein, P; Brendel, M; Kreth, FW; Muacevic, A; Nachbichler, SB; Romagna, A; Schmid-Tannwald, C; Tonn, JC; Unterrainer, M | 1 |
Ceccon, G; Filss, CP; Galldiks, N; Kamp, MA; Langen, KJ; Lohmann, P; Neumaier, B; Rapp, M; Sabel, M; Shah, NJ; Stegmayr, C; Stoffels, G | 1 |
Förster, S; Gempt, J; Göttler, J; Kaczmarz, S; Kluge, A; Lukas, M; Meyer, B; Mustafa, M; Preibisch, C; Pyka, T; Ringel, F; Schwaiger, M; Zimmer, C | 1 |
Chatelut, E; Concordet, D; de Mey, J; de Ridder, M; Duerinck, J; Everaert, H; Gandia, P; Heemskerk, J; Jaudet, C; Neyns, B; Vanbinst, AM | 1 |
Bundschuh, RA; Essler, M; Fimmers, R; Gaertner, FC; Glas, M; Hattingen, E; Herrlinger, U; Kebir, S; Khurshid, Z; Scheffler, B | 1 |
Chan, M; Hsiao, E | 1 |
Albert, NL; Bartenstein, P; Belka, C; Fleischmann, DF; Niyazi, M; Unterrainer, M | 1 |
Costa, JC; Engelholm, SA; Law, I; Lundemann, M; Muhic, A; Munck Af Rosenschold, P; Poulsen, HS | 1 |
Arbizu, J; Galldiks, N; Langen, KJ; Law, I; Pope, WB | 1 |
Abbassi, RH; Day, BW; Font, JS; Hoque, M; Johns, TG; Kassiou, M; Munoz, L; Phoa, AF; Reekie, TA; Ryan, RM; Stringer, BW; Zhou, Q | 1 |
Fischman, AJ | 1 |
Bogner, L; Eilles, C; Koelbl, O; Rickhey, M | 1 |
Buchegger, F; Casanova, N; Dipasquale, G; Haller, G; Miralbell, R; Nouet, P; Ratib, O; Rouzaud, M; Vees, H; Weber, DC; Zaidi, H; Zilli, T | 1 |
Bärtschi, E; Bruehlmeier, M; Buettner, UW; Hefti, M; Hofer, S; Roelcke, U; Uhlmann, C; Wyss, M | 1 |
Buchfelder, M; Doelken, M; Ganslandt, O; Kuwert, T; Linke, R; Nimsky, C; Pölking, E; Prante, O; Stadlbauer, A | 1 |
Fonyuy, N; Horn, P; Koch, A; Misch, M; Plotkin, M; Stockhammer, F | 1 |
Bachofner, A; Coenen, HH; Floeth, FW; Hamacher, K; Herzog, H; Jansen, P; Langen, KJ; Pauleit, D; Reifenberger, G; Sabel, M; Stoffels, G; Tellmann, L | 1 |
Attieh, C; Demirel, C; Eble, MJ; Holy, R; Kaiser, HJ; Langen, KJ; Pinkawa, M; Piroth, MD; Stoffels, G | 1 |
Callahan, J; Drummond, E; Drummond, KJ; Grigg, A; Hicks, RJ; Hogg, A; Lau, EW; Ryan, G; Ware, RE | 1 |
Benouaich-Amiel, A; Bousquet, P; Cances-Lauwers, V; Clanet, M; Delisle, MB; Esquerré, JP; Gantet, P; Julian, A; Lubrano, V; Payoux, P; Roux, F; Sabatier, J; Sol, JC; Tafani, M; Tremoulet, M; Uro-coste, E | 1 |
Balogova, S; Giannesini, C; Gutman, F; Huchet, V; Izrael, V; Kerrou, K; Muresan, IP; Nataf, V; Pene, F; Prignon, A; Schlienger, M; Talbot, JN | 1 |
Aigner, RM; Dunzinger, A; Nussbaumer, K; Pichler, J; Pichler, R; Topakian, R; Weis, S; Wurm, G | 1 |
Blechschmidt, C; Czabanka, M; Koch, A; Misch, M; Plotkin, M; Stockhammer, F; Tuettenberg, J; Vajkoczy, P | 1 |
Birner, P; Guentchev, M; Natchev, S; Toumangelova-Uzeir, K | 1 |
Auf, G; Blechschmidt, C; Brenner, W; Denecke, T; Geworski, L; Nyuyki, F; Plotkin, M; Stockhammer, F | 1 |
Bogner, L; Eilles, C; Koelbl, O; Morávek, Z; Rickhey, M | 1 |
Coenen, HH; Eble, MJ; Holy, R; Kaiser, HJ; Klotz, J; Langen, KJ; Nussen, S; Pinkawa, M; Piroth, MD; Stoffels, G | 1 |
Buchfelder, M; Doerfler, A; Fritscher, T; Graf, W; Hammen, T; Kasper, BS; Kasper, EM; Kerling, F; Kuwert, T; Linke, R; Lorber, B; Pauli, E; Prante, O; Schwab, S; Stefan, H; Struffert, T; Weigel, D | 1 |
Houlden, H; Paisán-Ruiz, C | 1 |
Coenen, HH; Ewelt, C; Felsberg, J; Floeth, FW; Langen, KJ; Reifenberger, G; Sabel, M; Steiger, HJ; Stoffels, G; Stummer, W | 1 |
Egensperger, R; Eigenbrod, S; Geisler, J; Hartmann, C; Herms, J; Kreth, FW; Kreth, S; Kretzschmar, HA; Kunz, M; la Fougere, C; Linn, J; Lutz, J; Pöpperl, G; Thon, N; Tonn, JC; von Deimling, A | 1 |
Bartenstein, P; Belka, C; Ganswindt, U; Garny, S; Geisler, J; Kreth, FW; la Fougère, C; Niyazi, M; Schnell, O; Schwarz, SB; Siefert, A; Suchorska, B; Tonn, JC | 1 |
Altieri, S; Bortolussi, S; Burchielli, S; Del Guerra, A; Del Turco, S; Matteucci, M; Menichetti, L; Panetta, D; Pascali, G; Petroni, D; Salvadori, PA | 1 |
Coenen, HH; Eble, MJ; Galldiks, N; Herzog, H; Holy, R; Kaiser, HJ; Langen, KJ; Pinkawa, M; Piroth, MD; Stoffels, G | 1 |
Ewelt, C; Felsberg, J; Floeth, FW; Langen, KJ; Sabel, M; Steiger, HJ; Stoffels, G; Stummer, W | 1 |
Astner, ST; Grosu, AL; Heinemann, F; Molls, M; Nieder, C; Riedel, E; Schwaiger, M; Weber, WA; Wester, HJ; Wiedenmann, N | 1 |
Hussaini, IM; Lopes, MB; Merk, BC; Owens, JL; Silva, CM | 1 |
Gotwald, T; Hutterer, M; Jacobs, AH; Kostron, H; Muigg, A; Nowosielski, M; Putzer, D; Staffen, W; Stockhammer, G; Tinkhauser, G; Trinka, E; Virgolini, IJ; Waitz, D | 1 |
Buchfelder, M; Dörfler, A; Ganslandt, O; Grummich, P; Hammen, T; Kuwert, T; Nimsky, C; Stadlbauer, A | 1 |
Anile, C; Baum, RP; Calcagni, ML; Galli, G; Giordano, A; Niesen, A; Taralli, S | 1 |
Bruehlmeier, M; Hefti, M; Hundsberger, T; Nitzsche, EU; Roelcke, U | 1 |
Buck, A; Dunet, V; Prior, JO; Rossier, C; Stupp, R | 1 |
Heinzel, A; Langen, KJ; Müller, D; Stock, S | 1 |
Jeong, SY; Lim, SM | 1 |
Angelidis, G; Georgoulias, P; Leondi, A; Psimadas, D; Valotassiou, V | 1 |
Coenen, HH; Eble, MJ; Filss, CP; Fink, GR; Galldiks, N; Holy, R; Kaiser, HJ; Langen, KJ; Nolte, KW; Pinkawa, M; Piroth, MD; Stoffels, G | 1 |
Bartenstein, P; Belka, C; Eigenbrod, S; Ganswindt, U; Geisler, J; Kreth, FW; la Fougère, C; Niyazi, M; Schnell, O; Schwarz, SB; Suchorska, B; Tonn, JC | 1 |
Coenen, HH; Filss, CP; Fink, GR; Galldiks, N; Herzog, H; Langen, KJ; Piroth, MD; Ruge, MI; Sabel, M; Shah, NJ; Stoffels, G | 1 |
Bachoo, RM; Cavenee, WK; Dang, J; DePinho, RA; Fenton, TR; Furnari, FB; Inda, MM; Iwanami, A; James, CD; Kuga, D; Marie, SK; Mischel, PS; Nathanson, D; Oba-Shinjo, SM; Ponte de Albuquerque, C; Tanaka, K; Uno, M; Vandenberg, SR; Wykosky, J; Yang, H; Zhou, H | 1 |
Coenen, HH; Fink, GR; Galldiks, N; Langen, KJ; Rapp, M; Sabel, M; Shah, NJ; Stoffels, G | 1 |
Belka, C; Büsing, K; Eigenbrod, S; Ganswindt, U; Geisler, J; Jansen, N; la Fougère, C; Niyazi, M; Schnell, O; Schwarz, SB | 1 |
Beez, T; Coenen, HH; Ewelt, C; Felsberg, J; Floeth, FW; Galldiks, N; Heinzel, A; Langen, KJ; Rapp, M; Reifenberger, G; Sabel, M; Steiger, HJ; Stoffels, G | 1 |
Göbel, G; Hutterer, M; Jacobs, AH; Jansen, NL; la Fougère, C; McCoy, M; Nowosielski, M; Putzer, D; Schocke, M; Seiz, M; Stockhammer, G; Trinka, E; Virgolini, IJ | 1 |
Felsberg, J; Floeth, FW; Galldiks, N; Langen, KJ; Rapp, M; Sabel, M; Steiger, HJ | 1 |
Cattaneo, MG; Francolini, M; Massari, S; Perego, C; Pietrini, G; Pola, S; Raimondi, A; Vanoni, C; Vicentini, LM | 1 |
Archer, GE; Bigner, DD; Chewning, TA; Friedman, AH; Friedman, HS; Heimberger, AB; Learn, CA; McLendon, RE; Pracyk, JB; Sampson, JH; Tuck, FL | 1 |
Coenen, HH; Floeth, F; Hamacher, K; Herzog, H; Langen, KJ; Müller, HW; Pauleit, D; Tellmann, L | 1 |
Bröer, S; Coenen, HH; Hamacher, K; Jansen, P; Jarosch, M; Langen, KJ; Mühlensiepen, H; Zilles, K | 1 |
Cheng, X; Dang, YH; Wang, SZ; Zhou, Q | 1 |
SHAMIRZAEV, AIu | 1 |
Coenen, HH; Floeth, F; Hamacher, K; Hautzel, H; Langen, KJ; Müller, HW; Pauleit, D; Tellmann, L | 1 |
Egorin, MJ; Ilaria, RL; Minna, JD; Randle, DE; Wolff, NC | 1 |
Gildehaus, FJ; Götz, C; Pöpperl, G; Rachinger, W; Tatsch, K; Tonn, JC | 1 |
Diestel, S; Laurini, C; Schmitz, B; Traub, O | 1 |
Aguzzi, A; Buck, A; Hermann, DM; Kaser-Hotz, B; Lutz, A; Pahnke, J; Radovanovic, I; Scheidegger, S; Spaeth, N; Verwey, J; Weber, B; Weishaupt, D; Westera, G; Wild, D; Wyss, MT | 1 |
Coenen, HH; Hamacher, K; Kloska, S; Kurlemann, G; Langen, KJ; Rickert, CH; Schober, O; Straeter, R; Wassmann, H; Weckesser, M | 1 |
Coenen, HH; Floeth, F; Hamacher, K; Langen, KJ; Müller, HW; Pauleit, D; Reifenberger, G; Riemenschneider, MJ; Zilles, K | 1 |
Coenen, H; Floeth, FW; Hamacher, K; Langen, KJ; Messing-Jünger, M; Müller, HW; Pauleit, D; Reifenberger, G; Sabel, M; Steiger, HJ; Stummer, W; Weber, F; Wittsack, HJ; Woebker, G; Zilles, K | 1 |
Harada, N; Ishii, K; Ishiwata, K; Iwata, R; Kawamura, K; Kimura, Y; Kubota, K; Nariai, T; Oda, K; Tsukada, H | 1 |
Gildehaus, FJ; Goldbrunner, R; Holtmannspötter, M; Kreth, FW; Pöpperl, G; Tanner, P; Tatsch, K; Tonn, JC | 1 |
Chang, CW; Chen, JC; Hwang, JJ; Hwang, LC; Lee, TW; Liu, RS; Wang, HE; Wu, SY | 1 |
Bauer, D; Coenen, HH; Floeth, FW; Hamacher, K; Langen, KJ; Pauleit, D; Reifenberger, G; Stoffels, G; Zilles, K | 1 |
Amoresano, A; Cioffi, FA; Columbano, L; d'Ischia, M; Di Cosmo, A; Di Cristo, C; Fiore, G; Monti, G; Palumbo, A; Pucci, P | 1 |
Chan, CH; Chan, SY; Lee, RH; Wong, WL | 1 |
Gildehaus, FJ; Herms, J; Koch, W; Kreth, FW; Kretzschmar, HA; Mehrkens, JH; Pöpperl, G; Tatsch, K; Tonn, JC | 1 |
Biollaz, G; Buck, A; Goepfert, K; Lutz, A; Pahnke, J; Spaeth, N; Treyer, V; Weber, B; Westera, G; Wyss, MT | 1 |
Gildehaus, FJ; Götz, C; Pöpperl, G; Rachinger, W; Schnell, O; Tatsch, K; Tonn, JC | 1 |
Bauer, D; Coenen, HH; Floeth, F; Hamacher, K; Langen, KJ; Pauleit, D; Stoffels, G; Weckesser, M | 1 |
Amthauer, H; Denecke, T; Felix, R; Feussner, A; Gneveckow, U; Gutberlet, M; Jordan, A; Meier-Hauff, K; Plotkin, M; Wust, P | 1 |
An, GI; Cheon, GJ; Chi, DY; Choi, CW; Chun, KS; Lee, KC; Lee, TS; Lim, SM; Moon, BS | 1 |
Bigner, DD; Friedman, HS; Hjelmeland, AB; Jackson, D; Keir, ST; Ohmori, O; Rich, JN; Shi, Q; Song, L; Wickman, S | 1 |
Bauer, R; Brust, P; Fischer, S; Ganapathy, V; Herzau, M; Hinz, R; Huggel, K; Makrides, V; Opfermann, T; Verrey, F; Weber, W; Wester, HJ | 1 |
Alessi, P; Biollaz, G; Buck, A; Neri, D; Pahnke, J; Spaeth, N; Trachsel, E; Treyer, V; Weber, B; Wyss, MT | 1 |
Bärtschi, E; Hefti, M; Hofer, S; Roelcke, U; Treyer, V; Uhlmann, C; Wyss, MT | 1 |
Britt, WJ; Cobbs, CS; Denham, S; Kraus, MH; Pieper, R; Soroceanu, L; Zhang, W | 1 |
Gildehaus, FJ; Herms, J; Koch, W; Kreth, FW; Kretzschmar, HA; Mehrkens, JH; Pöpperl, G; Seelos, K; Tatsch, K; Tonn, JC | 1 |
Herms, J; Kreth, FW; Mehrkens, JH; Pöpperl, G; Rachinger, W; Seelos, K; Tatsch, K; Tonn, JC | 1 |
Coenen, HH; Floeth, FW; Hamacher, K; Langen, KJ; Pauleit, D; Stoffels, G | 1 |
Bosch, DA; Habraken, JB; Hulshof, MC; Koot, RW; Paans, AM; Pruim, J | 1 |
Amthauer, H; Plotkin, M; Stockhammer, F; van Landeghem, FK; Woiciechowsky, C | 1 |
Becker, DP; Gadisseux, P; Ward, JD; Young, HF | 1 |
Franssen, EJ; Go, KG; Heesters, MA; Molenaar, WM; Paans, AM; Pruim, J; Vaalburg, W; van Waarde, A; Visser, GM; Willemsen, AT | 1 |
Chang, KJ; Chung, NN; Lee, PH; Nguyen, TM; Schiller, PW | 1 |
Chen, JK; Cheng, HP; Hung, LM; Tsai, CH | 1 |
Go, KG; Luurtsema, G; Paans, AM; Pruim, J; Vaalburg, W; van Waarde, A; Willemsen, AT | 1 |
Go, KG; Kamman, RL; Keuter, EJ; Metzemaekers, JD; Paans, AM; Pruim, J; Staal, MJ; Vaalburg, W | 1 |
de Wolde, H; Koudstaal, J; Mastik, MF; Molenaar, WM; Pruim, J | 1 |
Blomquist, E; Bolander, H; Carlsson, J; Gedda, L; Hartvig, P; Janson, J; Lundqvist, H; Mellstedt, H; Nilsson, S; Nistèr, M; Sundin, A; Tolmachev, V; Westlin, J; Zhao, Q | 1 |
Heiss, P; Herz, M; Schwaiger, M; Senekowitsch-Schmidtke, R; Stöcklin, G; Weber, W; Wester, HJ | 1 |
Chen, F; Coy, DH; Diaco, DS; Drouant, GJ; Espenan, GD; Fisher, DR; Fuselier, JA; Maloney, TM; Murphy, WA; Nelson, JA; O'Dorisio, MS; O'Dorisio, TM; Sharma, C; Woltering, EA | 1 |
Kolchinsky, A | 1 |
Menter, DG; Schaefer, LK; Schaefer, TS | 1 |
Dzewas, B; Feldmann, HJ; Grosu, AL; Herz, M; Molls, M; Schwaiger, M; Stöcklin, G; Weber, WA; Wester, HJ | 1 |
Kreutzfeld, R; Preuss, U; Scheidtmann, KH | 1 |
Ali-Osman, F; Mullapudi, SR; Shou, J; Srivenugopal, KS | 1 |
Arun, P; Deepadevi, KV; Kurup, PA; Manojkumar, V; Ravikumar, A | 1 |
Arun, P; Devi, KV; Kurup, PA; Ravikumar, A | 1 |
de Vries, EG; Jager, PL; Langen, KJ; Piers, DA; Pruim, J; Vaalburg, W | 1 |
Bedecs, K; Lindegren, H; Ostlund, P; Pettersson, C | 1 |
Szydlowska, H | 1 |
Andersson, A; Capala, J; Carlsson, J | 1 |
Coenen, HH; Heiss, WD; Herholz, K; Kling, P; Rudolf, J; Stöcklin, G; Wienhard, K | 1 |
Bakker, WH; Krenning, EP; Lamberts, SW; Reubi, JC | 1 |
Chen, QZ; Dong, YJ; Liu, BH; Shao, KS; Wang, YH; Xu, FH; Xu, HJ; Xu, JJ; Xu, JP; Zhu, SL | 1 |
Abdullakhozhaeva, MS; Dimant, IN; Faĭn, NG | 1 |
Anton, AH; Greer, M; Williams, CM | 1 |
20 review(s) available for tyrosine and Benign Neoplasms, Brain
Article | Year |
---|---|
Utility of Amino Acid PET in the Differential Diagnosis of Recurrent Brain Metastases and Treatment-Related Changes: A Meta-analysis.
Topics: Amino Acids; Brain Neoplasms; Diagnosis, Differential; Humans; Methionine; Positron-Emission Tomography; Sensitivity and Specificity; Tyrosine | 2023 |
18F-FET-PET imaging in high-grade gliomas and brain metastases: a systematic review and meta-analysis.
Topics: Brain Neoplasms; Contrast Media; Gadolinium; Glioma; Humans; Magnetic Resonance Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Tyrosine | 2023 |
Current trends in the use of O-(2-[
Topics: Animals; Brain Neoplasms; Humans; Tyrosine | 2021 |
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acrylic Resins; Actinobacillus; Acute Disease; Acute Kidney Injury; Adaptor Proteins, Signal Transducing; Adenosine; Adenosine Triphosphate; Administration, Inhalation; Administration, Oral; Adolescent; Adult; Advance Care Planning; Africa, Northern; Age Factors; Aged; Aged, 80 and over; Air Pollutants; Air Pollution; Air Pollution, Indoor; Albendazole; Aluminum Oxide; Anastomosis, Surgical; Ancylostoma; Ancylostomiasis; Androstadienes; Angiogenesis Inhibitors; Angiotensin II; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bispecific; Antibodies, Viral; Anticoagulants; Antihypertensive Agents; Antinematodal Agents; Antineoplastic Agents; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antiporters; Antiviral Agents; Apoptosis; Aptamers, Nucleotide; Aromatase Inhibitors; Asian People; Astrocytes; Atrial Fibrillation; Auditory Threshold; Aurora Kinase B; Australia; Autophagy; Autophagy-Related Protein 5; Autotrophic Processes; Bacillus cereus; Bacillus thuringiensis; Bacterial Proteins; Beclin-1; Belgium; Benzene; Benzene Derivatives; Benzhydryl Compounds; beta Catenin; beta-Arrestin 2; Biliary Tract Diseases; Biofilms; Biofuels; Biomarkers; Biomarkers, Tumor; Biomass; Biomechanical Phenomena; Bioreactors; Biosensing Techniques; Biosynthetic Pathways; Bismuth; Blood Platelets; Bone and Bones; Bone Regeneration; Bortezomib; Botulinum Toxins, Type A; Brain; Brain Injuries; Brain Ischemia; Brain Neoplasms; Breast Neoplasms; Breath Tests; Bronchodilator Agents; Calcium Phosphates; Cannabis; Carbon Dioxide; Carbon Isotopes; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cardiac Resynchronization Therapy; Cardiac Resynchronization Therapy Devices; Cardiomyopathies; Cardiovascular Diseases; Cariostatic Agents; Case Managers; Case-Control Studies; Catalysis; Cation Transport Proteins; CD8-Positive T-Lymphocytes; Cecropia Plant; Cell Adhesion; Cell Count; Cell Differentiation; Cell Division; Cell Line; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Self Renewal; Cell Survival; Cells, Cultured; Cellular Reprogramming; Cellulose; Charcoal; Chemical and Drug Induced Liver Injury; Chemical Phenomena; Chemokines; Chemoradiotherapy; Chemoreceptor Cells; Child; Child Abuse; Child, Preschool; China; Chlorogenic Acid; Chloroquine; Chromatography, Gas; Chronic Disease; Clinical Competence; Coated Materials, Biocompatible; Cochlea; Cohort Studies; Color; Comorbidity; Computer Simulation; Computer-Aided Design; Contraception; Contraceptive Agents, Female; Contrast Media; COP-Coated Vesicles; Coronavirus Infections; Cost of Illness; Coturnix; COVID-19; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Culex; Curriculum; Cyclic N-Oxides; Cytokines; Cytoplasm; Cytotoxicity, Immunologic; Cytotoxins; Databases, Factual; Deep Learning; Delivery, Obstetric; Denitrification; Dental Caries; Denture, Complete; Dexamethasone; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dielectric Spectroscopy; Diet, High-Fat; Dietary Fiber; Disease Models, Animal; Disease Progression; DNA; DNA Copy Number Variations; DNA, Mitochondrial; Dog Diseases; Dogs; Dopaminergic Neurons; Double-Blind Method; Down-Regulation; Doxorubicin; Drug Carriers; Drug Design; Drug Interactions; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug-Related Side Effects and Adverse Reactions; Drugs, Chinese Herbal; Dry Powder Inhalers; Dust; E2F1 Transcription Factor; Ecosystem; Education, Nursing; Education, Nursing, Baccalaureate; Electric Impedance; Electricity; Electrocardiography; Electrochemical Techniques; Electrochemistry; Electrodes; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Endothelial Cells; Environmental Monitoring; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Estrogen Receptor Modulators; Europe; Evoked Potentials, Auditory, Brain Stem; Exosomes; Feasibility Studies; Female; Ferricyanides; Ferrocyanides; Fibrinogen; Finite Element Analysis; Fistula; Fluorescent Dyes; Fluorides, Topical; Fluorodeoxyglucose F18; Fluticasone; Follow-Up Studies; Food Contamination; Food Microbiology; Foods, Specialized; Forensic Medicine; Frail Elderly; France; Free Radicals; Fresh Water; Fungi; Fungicides, Industrial; Galactosamine; Gastrointestinal Neoplasms; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Frequency; Genetic Predisposition to Disease; Genotype; Gingival Hemorrhage; Glioblastoma; Glioma; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Glucose; Glucose Transport Proteins, Facilitative; Glucosides; Glutamine; Glycolysis; Gold; GPI-Linked Proteins; Gram-Negative Bacteria; Gram-Positive Bacteria; Graphite; Haplotypes; HCT116 Cells; Healthy Volunteers; Hearing Loss; Heart Failure; Hedgehog Proteins; HEK293 Cells; HeLa Cells; Hemodynamics; Hemorrhage; Hepatocytes; Hippo Signaling Pathway; Histone Deacetylases; Homeostasis; Hospital Mortality; Hospitalization; Humans; Hydantoins; Hydrazines; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Hydroxylamines; Hypoglycemic Agents; Immunity, Innate; Immunoglobulin G; Immunohistochemistry; Immunologic Factors; Immunomodulation; Immunophenotyping; Immunotherapy; Incidence; Indazoles; Indonesia; Infant; Infant, Newborn; Infarction, Middle Cerebral Artery; Inflammation; Injections, Intramuscular; Insecticides; Insulin-Like Growth Factor I; Insurance, Health; Intention to Treat Analysis; Interleukin-1 Receptor-Associated Kinases; Interleukin-6; Intrauterine Devices; Intrauterine Devices, Copper; Iron; Ischemia; Jordan; Keratinocytes; Kidney; Kidney Diseases; Kir5.1 Channel; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Laparoscopy; Lasers; Lasers, Semiconductor; Lenalidomide; Leptin; Lethal Dose 50; Levonorgestrel; Limit of Detection; Lipid Metabolism; Lipid Metabolism Disorders; Lipogenesis; Lipopolysaccharides; Liquid Biopsy; Liver; Liver Abscess, Pyogenic; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Longevity; Lung Neoplasms; Luteolin; Lymph Nodes; Lymphocyte Activation; Macaca fascicularis; Macrophages; Mad2 Proteins; Magnetic Resonance Imaging; Male; Mammary Glands, Human; Manganese; Manganese Compounds; MAP Kinase Signaling System; Materials Testing; Maternal Health Services; MCF-7 Cells; Medicaid; Medicine, Chinese Traditional; Melanoma; Membrane Proteins; Mental Health; Mercury; Metal Nanoparticles; Metals, Heavy; Metformin; Methionine Adenosyltransferase; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Knockout; Mice, Nude; Microalgae; Microbial Sensitivity Tests; Microglia; MicroRNAs; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Middle Aged; Mitochondria; Mitochondrial Proteins; Mitral Valve; Mitral Valve Insufficiency; Models, Anatomic; Molecular Structure; Molybdenum; Monocarboxylic Acid Transporters; Moths; MPTP Poisoning; Multigene Family; Multiparametric Magnetic Resonance Imaging; Multiple Myeloma; Muscle, Skeletal; Mutagens; Mutation; Myeloid Cells; Nanocomposites; Nanofibers; Nanomedicine; Nanoparticles; Nanowires; Neoadjuvant Therapy; Neomycin; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasms; Neoplastic Stem Cells; Neostriatum; Neovascularization, Pathologic; Netherlands; Neuromuscular Agents; Neurons; NF-E2-Related Factor 2; NF-kappa B; Nickel; Nitrogen Oxides; Non-alcoholic Fatty Liver Disease; Nucleosides; Nucleotidyltransferases; Nutritional Status; Obesity, Morbid; Ofloxacin; Oils, Volatile; Oligopeptides; Oncogene Protein v-akt; Optical Imaging; Organic Cation Transport Proteins; Organophosphonates; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Osteoblasts; Osteogenesis; Oxidation-Reduction; Oxidative Stress; Oxides; Oxygen Isotopes; Pancreas; Pancreaticoduodenectomy; Pandemics; Particle Size; Particulate Matter; Patient Acceptance of Health Care; Patient Compliance; PC-3 Cells; Peptide Fragments; Peptides; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Periodontitis; Peroxides; Peru; Pest Control, Biological; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Phylogeny; Pilot Projects; Piperidines; Plant Bark; Plant Extracts; Plant Leaves; Plasmids; Platelet Function Tests; Pneumonia, Viral; Podocytes; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Polyethylene Terephthalates; Polymers; Polymorphism, Single Nucleotide; Porosity; Portugal; Positron-Emission Tomography; Postoperative Complications; Postural Balance; Potassium Channels, Inwardly Rectifying; Povidone; Powders; Precancerous Conditions; Precision Medicine; Predictive Value of Tests; Pregnancy; Prenatal Care; Prognosis; Promoter Regions, Genetic; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Proteasome Inhibitors; Protective Agents; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Transport; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Psychiatric Nursing; PTEN Phosphohydrolase; Pulmonary Embolism; Pyrimethamine; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reactive Oxygen Species; Receptor, ErbB-2; Receptor, IGF Type 1; Receptors, Estrogen; Receptors, G-Protein-Coupled; Recombinational DNA Repair; Recovery of Function; Regional Blood Flow; Renal Dialysis; Renin; Renin-Angiotensin System; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Distress Syndrome; Retrospective Studies; Rhodamines; Risk Assessment; Risk Factors; RNA, Long Noncoding; RNA, Messenger; Running; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salinity; Salmeterol Xinafoate; Sarcoma; Seasons; Shoulder Injuries; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Sirtuins; Skull Fractures; Social Determinants of Health; Sodium; Sodium Fluoride; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Glucose Transporter 2 Inhibitors; Soil; Soil Pollutants; Spain; Spectrophotometry; Spectroscopy, Fourier Transform Infrared; Staphylococcal Protein A; Staphylococcus aureus; Stem Cells; Stereoisomerism; Stomach Neoplasms; Streptomyces; Strontium; Structure-Activity Relationship; Students, Nursing; Substance-Related Disorders; Succinic Acid; Sulfur; Surface Properties; Survival Rate; Survivin; Symporters; T-Lymphocytes; Temozolomide; Tensile Strength; Thiazoles; Thiobacillus; Thiohydantoins; Thiourea; Thrombectomy; Time Factors; Titanium; Tobacco Mosaic Virus; Tobacco Use Disorder; Toll-Like Receptor 4; Toluene; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Toxicity Tests, Acute; Toxicity Tests, Subacute; Transcriptional Activation; Treatment Outcome; Troponin I; Tumor Cells, Cultured; Tumor Escape; Tumor Hypoxia; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Tyrosine; Ubiquitin-Protein Ligases; Ubiquitination; Ultrasonic Waves; United Kingdom; United States; United States Department of Veterans Affairs; Up-Regulation; Urea; Uric Acid; Urinary Bladder Neoplasms; Urinary Bladder, Neurogenic; Urine; Urodynamics; User-Computer Interface; Vemurafenib; Verbenaceae; Veterans; Veterans Health; Viral Load; Virtual Reality; Vitiligo; Water Pollutants, Chemical; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Xylenes; Young Adult; Zinc; Zinc Oxide; Zinc Sulfate; Zoonoses | 2021 |
Imaging of amino acid transport in brain tumours: Positron emission tomography with O-(2-[
Topics: Animals; Brain Neoplasms; Humans; Positron-Emission Tomography; Protein Transport; Tyrosine | 2017 |
Methods for molecular imaging of brain tumours in a hybrid MR-PET context: Water content, T
Topics: Animals; Brain Neoplasms; Diffusion; Humans; Magnetic Resonance Imaging; Molecular Imaging; Positron-Emission Tomography; Tyrosine; Water | 2017 |
Recent Developments of 18F-FET PET in Neuro-oncology.
Topics: Brain Neoplasms; Humans; Positron-Emission Tomography; Tyrosine | 2018 |
Accuracy of
Topics: Brain Neoplasms; Diagnosis, Differential; Dihydroxyphenylalanine; Humans; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Prospective Studies; Radiation Injuries; Retrospective Studies; Tyrosine | 2018 |
Amino acid tracers in PET imaging of diffuse low-grade gliomas: a systematic review of preoperative applications.
Topics: Brain Neoplasms; Carbon Radioisotopes; Glioma; Humans; Methionine; Positron-Emission Tomography; Preoperative Period; Radiopharmaceuticals; Tyrosine | 2018 |
O-(2-[18F]-Fluoroethyl)-L-Tyrosine (FET) in Neurooncology: A Review of Experimental Results.
Topics: Animals; Biological Transport; Blood-Brain Barrier; Brain Neoplasms; Fluorine Radioisotopes; Humans; Medical Oncology; Microvessels; Radiopharmaceuticals; Tyrosine | 2019 |
Comparison Between 18F-Dopa and 18F-Fet PET/CT in Patients with Suspicious Recurrent High Grade Glioma: A Literature Review and Our Experience.
Topics: Brain Neoplasms; Dihydroxyphenylalanine; Glioma; Humans; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Tyrosine | 2019 |
Performance of 18F-FDG, 11C-Methionine, and 18F-FET PET for Glioma Grading: A Meta-analysis.
Topics: Brain Neoplasms; Carbon Radioisotopes; Fluorodeoxyglucose F18; Glioma; Humans; Methionine; Neoplasm Grading; Positron-Emission Tomography; Tyrosine | 2019 |
[Gliomas – What I Have to Know in ten Questions].
Topics: Anticoagulants; Anticonvulsants; Brain Neoplasms; Combined Modality Therapy; Dexamethasone; Diagnosis, Differential; Glioblastoma; Glioma; Humans; Image Interpretation, Computer-Assisted; Magnetic Resonance Imaging; Oligodendroglioma; Positron-Emission Tomography; Tyrosine | 2016 |
The use of amino acid PET and conventional MRI for monitoring of brain tumor therapy.
Topics: Amino Acids; Brain Neoplasms; Dihydroxyphenylalanine; Humans; Methionine; Positron-Emission Tomography; Radiopharmaceuticals; Tyrosine | 2017 |
PET imaging of brain tumors.
Topics: Biopsy; Brain; Brain Neoplasms; Cell Proliferation; Diagnostic Imaging; Dihydroxyphenylalanine; Fluorodeoxyglucose F18; Humans; Lipids; Medical Oncology; Methionine; Positron-Emission Tomography; Radiopharmaceuticals; Tyrosine | 2008 |
Performance of 18F-fluoro-ethyl-tyrosine (18F-FET) PET for the differential diagnosis of primary brain tumor: a systematic review and Metaanalysis.
Topics: Animals; Brain Neoplasms; Diagnosis, Differential; Glioma; Humans; Positron-Emission Tomography; Quality Control; Tyrosine | 2012 |
Clinical value of O-(2-[(18)F]-fluoroethyl)-L-tyrosine positron emission tomography in patients with low-grade glioma.
Topics: Animals; Brain Neoplasms; Glioma; Humans; Neoplasm Grading; Neoplasm Recurrence, Local; Positron-Emission Tomography; Tyrosine | 2013 |
O-(2-[18F]fluoroethyl)-L-tyrosine: uptake mechanisms and clinical applications.
Topics: Animals; Biological Transport; Brain Neoplasms; Fluorine Radioisotopes; Humans; Positron-Emission Tomography; Tyrosine | 2006 |
Nutrition and the neurosurgical patient.
Topics: Acetylcholine; Brain; Brain Injuries; Brain Neoplasms; Catecholamines; Choline; Endocrine Glands; Energy Metabolism; Humans; Nitrogen; Nutritional Physiological Phenomena; Serotonin; Tryptophan; Tyrosine | 1984 |
Radiolabeled amino acids: basic aspects and clinical applications in oncology.
Topics: Amino Acids; Brain Neoplasms; Breast Neoplasms; Carbon Radioisotopes; Head and Neck Neoplasms; Humans; Iodine Radioisotopes; Lung Neoplasms; Lymphoma; Methionine; Methyltyrosines; Neoplasms; Radionuclide Imaging; Radiopharmaceuticals; Tyrosine | 2001 |
25 trial(s) available for tyrosine and Benign Neoplasms, Brain
Article | Year |
---|---|
[
Topics: Adolescent; Adult; Australia; Brain Neoplasms; Clinical Trials, Phase II as Topic; Ficus; Glioblastoma; Humans; Magnetic Resonance Imaging; Multicenter Studies as Topic; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prospective Studies; Tyrosine | 2023 |
Boosting the acceptance of
Topics: Brain Neoplasms; Humans; Magnetic Resonance Imaging; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Tyrosine | 2023 |
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acrylic Resins; Actinobacillus; Acute Disease; Acute Kidney Injury; Adaptor Proteins, Signal Transducing; Adenosine; Adenosine Triphosphate; Administration, Inhalation; Administration, Oral; Adolescent; Adult; Advance Care Planning; Africa, Northern; Age Factors; Aged; Aged, 80 and over; Air Pollutants; Air Pollution; Air Pollution, Indoor; Albendazole; Aluminum Oxide; Anastomosis, Surgical; Ancylostoma; Ancylostomiasis; Androstadienes; Angiogenesis Inhibitors; Angiotensin II; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bispecific; Antibodies, Viral; Anticoagulants; Antihypertensive Agents; Antinematodal Agents; Antineoplastic Agents; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antiporters; Antiviral Agents; Apoptosis; Aptamers, Nucleotide; Aromatase Inhibitors; Asian People; Astrocytes; Atrial Fibrillation; Auditory Threshold; Aurora Kinase B; Australia; Autophagy; Autophagy-Related Protein 5; Autotrophic Processes; Bacillus cereus; Bacillus thuringiensis; Bacterial Proteins; Beclin-1; Belgium; Benzene; Benzene Derivatives; Benzhydryl Compounds; beta Catenin; beta-Arrestin 2; Biliary Tract Diseases; Biofilms; Biofuels; Biomarkers; Biomarkers, Tumor; Biomass; Biomechanical Phenomena; Bioreactors; Biosensing Techniques; Biosynthetic Pathways; Bismuth; Blood Platelets; Bone and Bones; Bone Regeneration; Bortezomib; Botulinum Toxins, Type A; Brain; Brain Injuries; Brain Ischemia; Brain Neoplasms; Breast Neoplasms; Breath Tests; Bronchodilator Agents; Calcium Phosphates; Cannabis; Carbon Dioxide; Carbon Isotopes; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cardiac Resynchronization Therapy; Cardiac Resynchronization Therapy Devices; Cardiomyopathies; Cardiovascular Diseases; Cariostatic Agents; Case Managers; Case-Control Studies; Catalysis; Cation Transport Proteins; CD8-Positive T-Lymphocytes; Cecropia Plant; Cell Adhesion; Cell Count; Cell Differentiation; Cell Division; Cell Line; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Self Renewal; Cell Survival; Cells, Cultured; Cellular Reprogramming; Cellulose; Charcoal; Chemical and Drug Induced Liver Injury; Chemical Phenomena; Chemokines; Chemoradiotherapy; Chemoreceptor Cells; Child; Child Abuse; Child, Preschool; China; Chlorogenic Acid; Chloroquine; Chromatography, Gas; Chronic Disease; Clinical Competence; Coated Materials, Biocompatible; Cochlea; Cohort Studies; Color; Comorbidity; Computer Simulation; Computer-Aided Design; Contraception; Contraceptive Agents, Female; Contrast Media; COP-Coated Vesicles; Coronavirus Infections; Cost of Illness; Coturnix; COVID-19; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Culex; Curriculum; Cyclic N-Oxides; Cytokines; Cytoplasm; Cytotoxicity, Immunologic; Cytotoxins; Databases, Factual; Deep Learning; Delivery, Obstetric; Denitrification; Dental Caries; Denture, Complete; Dexamethasone; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dielectric Spectroscopy; Diet, High-Fat; Dietary Fiber; Disease Models, Animal; Disease Progression; DNA; DNA Copy Number Variations; DNA, Mitochondrial; Dog Diseases; Dogs; Dopaminergic Neurons; Double-Blind Method; Down-Regulation; Doxorubicin; Drug Carriers; Drug Design; Drug Interactions; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug-Related Side Effects and Adverse Reactions; Drugs, Chinese Herbal; Dry Powder Inhalers; Dust; E2F1 Transcription Factor; Ecosystem; Education, Nursing; Education, Nursing, Baccalaureate; Electric Impedance; Electricity; Electrocardiography; Electrochemical Techniques; Electrochemistry; Electrodes; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Endothelial Cells; Environmental Monitoring; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Estrogen Receptor Modulators; Europe; Evoked Potentials, Auditory, Brain Stem; Exosomes; Feasibility Studies; Female; Ferricyanides; Ferrocyanides; Fibrinogen; Finite Element Analysis; Fistula; Fluorescent Dyes; Fluorides, Topical; Fluorodeoxyglucose F18; Fluticasone; Follow-Up Studies; Food Contamination; Food Microbiology; Foods, Specialized; Forensic Medicine; Frail Elderly; France; Free Radicals; Fresh Water; Fungi; Fungicides, Industrial; Galactosamine; Gastrointestinal Neoplasms; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Frequency; Genetic Predisposition to Disease; Genotype; Gingival Hemorrhage; Glioblastoma; Glioma; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Glucose; Glucose Transport Proteins, Facilitative; Glucosides; Glutamine; Glycolysis; Gold; GPI-Linked Proteins; Gram-Negative Bacteria; Gram-Positive Bacteria; Graphite; Haplotypes; HCT116 Cells; Healthy Volunteers; Hearing Loss; Heart Failure; Hedgehog Proteins; HEK293 Cells; HeLa Cells; Hemodynamics; Hemorrhage; Hepatocytes; Hippo Signaling Pathway; Histone Deacetylases; Homeostasis; Hospital Mortality; Hospitalization; Humans; Hydantoins; Hydrazines; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Hydroxylamines; Hypoglycemic Agents; Immunity, Innate; Immunoglobulin G; Immunohistochemistry; Immunologic Factors; Immunomodulation; Immunophenotyping; Immunotherapy; Incidence; Indazoles; Indonesia; Infant; Infant, Newborn; Infarction, Middle Cerebral Artery; Inflammation; Injections, Intramuscular; Insecticides; Insulin-Like Growth Factor I; Insurance, Health; Intention to Treat Analysis; Interleukin-1 Receptor-Associated Kinases; Interleukin-6; Intrauterine Devices; Intrauterine Devices, Copper; Iron; Ischemia; Jordan; Keratinocytes; Kidney; Kidney Diseases; Kir5.1 Channel; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Laparoscopy; Lasers; Lasers, Semiconductor; Lenalidomide; Leptin; Lethal Dose 50; Levonorgestrel; Limit of Detection; Lipid Metabolism; Lipid Metabolism Disorders; Lipogenesis; Lipopolysaccharides; Liquid Biopsy; Liver; Liver Abscess, Pyogenic; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Longevity; Lung Neoplasms; Luteolin; Lymph Nodes; Lymphocyte Activation; Macaca fascicularis; Macrophages; Mad2 Proteins; Magnetic Resonance Imaging; Male; Mammary Glands, Human; Manganese; Manganese Compounds; MAP Kinase Signaling System; Materials Testing; Maternal Health Services; MCF-7 Cells; Medicaid; Medicine, Chinese Traditional; Melanoma; Membrane Proteins; Mental Health; Mercury; Metal Nanoparticles; Metals, Heavy; Metformin; Methionine Adenosyltransferase; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Knockout; Mice, Nude; Microalgae; Microbial Sensitivity Tests; Microglia; MicroRNAs; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Middle Aged; Mitochondria; Mitochondrial Proteins; Mitral Valve; Mitral Valve Insufficiency; Models, Anatomic; Molecular Structure; Molybdenum; Monocarboxylic Acid Transporters; Moths; MPTP Poisoning; Multigene Family; Multiparametric Magnetic Resonance Imaging; Multiple Myeloma; Muscle, Skeletal; Mutagens; Mutation; Myeloid Cells; Nanocomposites; Nanofibers; Nanomedicine; Nanoparticles; Nanowires; Neoadjuvant Therapy; Neomycin; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasms; Neoplastic Stem Cells; Neostriatum; Neovascularization, Pathologic; Netherlands; Neuromuscular Agents; Neurons; NF-E2-Related Factor 2; NF-kappa B; Nickel; Nitrogen Oxides; Non-alcoholic Fatty Liver Disease; Nucleosides; Nucleotidyltransferases; Nutritional Status; Obesity, Morbid; Ofloxacin; Oils, Volatile; Oligopeptides; Oncogene Protein v-akt; Optical Imaging; Organic Cation Transport Proteins; Organophosphonates; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Osteoblasts; Osteogenesis; Oxidation-Reduction; Oxidative Stress; Oxides; Oxygen Isotopes; Pancreas; Pancreaticoduodenectomy; Pandemics; Particle Size; Particulate Matter; Patient Acceptance of Health Care; Patient Compliance; PC-3 Cells; Peptide Fragments; Peptides; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Periodontitis; Peroxides; Peru; Pest Control, Biological; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Phylogeny; Pilot Projects; Piperidines; Plant Bark; Plant Extracts; Plant Leaves; Plasmids; Platelet Function Tests; Pneumonia, Viral; Podocytes; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Polyethylene Terephthalates; Polymers; Polymorphism, Single Nucleotide; Porosity; Portugal; Positron-Emission Tomography; Postoperative Complications; Postural Balance; Potassium Channels, Inwardly Rectifying; Povidone; Powders; Precancerous Conditions; Precision Medicine; Predictive Value of Tests; Pregnancy; Prenatal Care; Prognosis; Promoter Regions, Genetic; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Proteasome Inhibitors; Protective Agents; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Transport; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Psychiatric Nursing; PTEN Phosphohydrolase; Pulmonary Embolism; Pyrimethamine; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reactive Oxygen Species; Receptor, ErbB-2; Receptor, IGF Type 1; Receptors, Estrogen; Receptors, G-Protein-Coupled; Recombinational DNA Repair; Recovery of Function; Regional Blood Flow; Renal Dialysis; Renin; Renin-Angiotensin System; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Distress Syndrome; Retrospective Studies; Rhodamines; Risk Assessment; Risk Factors; RNA, Long Noncoding; RNA, Messenger; Running; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salinity; Salmeterol Xinafoate; Sarcoma; Seasons; Shoulder Injuries; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Sirtuins; Skull Fractures; Social Determinants of Health; Sodium; Sodium Fluoride; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Glucose Transporter 2 Inhibitors; Soil; Soil Pollutants; Spain; Spectrophotometry; Spectroscopy, Fourier Transform Infrared; Staphylococcal Protein A; Staphylococcus aureus; Stem Cells; Stereoisomerism; Stomach Neoplasms; Streptomyces; Strontium; Structure-Activity Relationship; Students, Nursing; Substance-Related Disorders; Succinic Acid; Sulfur; Surface Properties; Survival Rate; Survivin; Symporters; T-Lymphocytes; Temozolomide; Tensile Strength; Thiazoles; Thiobacillus; Thiohydantoins; Thiourea; Thrombectomy; Time Factors; Titanium; Tobacco Mosaic Virus; Tobacco Use Disorder; Toll-Like Receptor 4; Toluene; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Toxicity Tests, Acute; Toxicity Tests, Subacute; Transcriptional Activation; Treatment Outcome; Troponin I; Tumor Cells, Cultured; Tumor Escape; Tumor Hypoxia; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Tyrosine; Ubiquitin-Protein Ligases; Ubiquitination; Ultrasonic Waves; United Kingdom; United States; United States Department of Veterans Affairs; Up-Regulation; Urea; Uric Acid; Urinary Bladder Neoplasms; Urinary Bladder, Neurogenic; Urine; Urodynamics; User-Computer Interface; Vemurafenib; Verbenaceae; Veterans; Veterans Health; Viral Load; Virtual Reality; Vitiligo; Water Pollutants, Chemical; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Xylenes; Young Adult; Zinc; Zinc Oxide; Zinc Sulfate; Zoonoses | 2021 |
MRI and
Topics: Aged; Aged, 80 and over; Bevacizumab; Brain; Brain Neoplasms; Chemoradiotherapy; Female; Glioblastoma; Humans; Isocitrate Dehydrogenase; Magnetic Resonance Imaging; Male; Positron-Emission Tomography; Progression-Free Survival; Radiopharmaceuticals; Tyrosine | 2021 |
Voxel-Wise Analysis of Fluoroethyltyrosine PET and MRI in the Assessment of Recurrent Glioblastoma During Antiangiogenic Therapy.
Topics: Angiogenesis Inhibitors; Bevacizumab; Brain Neoplasms; Female; Glioblastoma; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Predictive Value of Tests; Tyrosine | 2018 |
Report of first recurrent glioma patients examined with PET-MRI prior to re-irradiation.
Topics: Adolescent; Adult; Aged; Bevacizumab; Brain Neoplasms; Chemoradiotherapy; Female; Glioma; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Temozolomide; Tumor Burden; Tyrosine | 2019 |
Prognostic value of
Topics: Adult; Aged; Brain Neoplasms; Dose-Response Relationship, Radiation; Female; Glioma; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Re-Irradiation; Treatment Outcome; Tumor Burden; Tyrosine | 2016 |
[(18)F]Fluoroethyltyrosine- positron emission tomography-guided radiotherapy for high-grade glioma.
Topics: Adult; Aged; Brain Neoplasms; Female; Fluorine Radioisotopes; Glioma; Humans; Male; Middle Aged; Observer Variation; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Tyrosine | 2008 |
Early metabolic responses in temozolomide treated low-grade glioma patients.
Topics: Adult; Antineoplastic Agents, Alkylating; Brain Neoplasms; Dacarbazine; Female; Fluorine Radioisotopes; Follow-Up Studies; Glioma; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Temozolomide; Time Factors; Tyrosine; Young Adult | 2009 |
Comparison of (18)F-FET and (18)F-FDG PET in brain tumors.
Topics: Adolescent; Aged; Brain Neoplasms; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Positron-Emission Tomography; Prospective Studies; Tyrosine; Young Adult | 2009 |
Integrated-boost IMRT or 3-D-CRT using FET-PET based auto-contoured target volume delineation for glioblastoma multiforme--a dosimetric comparison.
Topics: Adult; Aged; Brain Neoplasms; Female; Glioblastoma; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Conformal; Radiotherapy, Intensity-Modulated; Tyrosine | 2009 |
Evaluation of O-(2-[18F]-Fluoroethyl)-L-Tyrosine in the Diagnosis of Glioblastoma.
Topics: Brain; Brain Neoplasms; Glioblastoma; Humans; Image Interpretation, Computer-Assisted; Image Processing, Computer-Assisted; Positron-Emission Tomography; Prospective Studies; Tyrosine | 2010 |
Comparison of (18)F-FET PET and 5-ALA fluorescence in cerebral gliomas.
Topics: Adult; Aged; Aminolevulinic Acid; Blood-Brain Barrier; Brain Neoplasms; Female; Gadolinium DTPA; Glioma; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Spectrometry, Fluorescence; Tyrosine | 2011 |
Comparison of 3'-deoxy-3'-[18F]fluorothymidine PET and O-(2-[18F]fluoroethyl)-L-tyrosine PET in patients with newly diagnosed glioma.
Topics: Adult; Aged; Brain Neoplasms; Dideoxynucleosides; Female; Glioma; Humans; Male; Middle Aged; Neoplasm Grading; Positron-Emission Tomography; Prognosis; Prospective Studies; Tyrosine | 2012 |
Response assessment of bevacizumab in patients with recurrent malignant glioma using [18F]Fluoroethyl-L-tyrosine PET in comparison to MRI.
Topics: Adult; Aged; Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Bevacizumab; Brain Neoplasms; Disease-Free Survival; Female; Glioma; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Treatment Outcome; Tyrosine | 2013 |
Comparison of O-(2-18F-fluoroethyl)-L-tyrosine PET and 3-123I-iodo-alpha-methyl-L-tyrosine SPECT in brain tumors.
Topics: Adult; Aged; Brain Neoplasms; Female; Fluorine Radioisotopes; Humans; Magnetic Resonance Imaging; Male; Methyltyrosines; Middle Aged; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon; Tyrosine | 2004 |
Value of O-(2-[18F]fluoroethyl)- L-tyrosine PET for the diagnosis of recurrent glioma.
Topics: Brain Neoplasms; Fluorine Radioisotopes; Glioma; Humans; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Treatment Outcome; Tyrosine | 2004 |
O-(2-[18F]fluorethyl)-L-tyrosine PET in the clinical evaluation of primary brain tumours.
Topics: Adolescent; Adult; Aged; Brain Neoplasms; Child; Child, Preschool; Female; Fluorine Radioisotopes; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tyrosine | 2005 |
Preclinical and clinical evaluation of O-[11C]methyl-L-tyrosine for tumor imaging by positron emission tomography.
Topics: Adult; Animals; Brain Neoplasms; Carcinoma, Hepatocellular; Cell Line, Tumor; Drug Evaluation, Preclinical; Female; Haplorhini; Humans; Inflammation; Male; Metabolic Clearance Rate; Oligodendroglioma; Organ Specificity; Positron-Emission Tomography; Radiopharmaceuticals; Rats; Survival Analysis; Tissue Distribution; Turpentine; Tyrosine | 2005 |
O-(2-[18F]fluoroethyl)-L-tyrosine PET for monitoring the effects of convection-enhanced delivery of paclitaxel in patients with recurrent glioblastoma.
Topics: Antineoplastic Agents; Brain Neoplasms; Convection; Drug Delivery Systems; Female; Glioblastoma; Humans; Infusions, Intralesional; Male; Middle Aged; Neoplasm Recurrence, Local; Paclitaxel; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Treatment Outcome; Tyrosine | 2005 |
Analysis of 18F-FET PET for grading of recurrent gliomas: is evaluation of uptake kinetics superior to standard methods?
Topics: Adult; Algorithms; Brain; Brain Neoplasms; Computer Simulation; Female; Glioma; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Kinetics; Male; Metabolic Clearance Rate; Middle Aged; Models, Biological; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; ROC Curve; Sensitivity and Specificity; Severity of Illness Index; Tyrosine | 2006 |
Serial O-(2-[(18)F]fluoroethyl)-L: -tyrosine PET for monitoring the effects of intracavitary radioimmunotherapy in patients with malignant glioma.
Topics: Adult; Brachytherapy; Brain Neoplasms; Female; Glioma; Humans; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Radioimmunotherapy; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Treatment Outcome; Tyrosine | 2006 |
18F-FET PET for planning of thermotherapy using magnetic nanoparticles in recurrent glioblastoma.
Topics: Adult; Aged; Brain Neoplasms; Female; Glioblastoma; Humans; Hyperthermia, Induced; Magnetic Resonance Imaging; Magnetics; Male; Middle Aged; Nanostructures; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiotherapy Planning, Computer-Assisted; Tyrosine | 2006 |
Synthesis and characterization of multiply-tyrosinated, multiply-iodinated somatostatin analogs.
Topics: Adenocarcinoma, Bronchiolo-Alveolar; Adenylyl Cyclase Inhibitors; Aged; Amino Acid Sequence; Brain Neoplasms; Diagnostic Imaging; Growth Hormone; Humans; Iodine; Lung Neoplasms; Male; Neuroblastoma; Peptides; Radionuclide Imaging; Somatostatin; Tissue Distribution; Tumor Cells, Cultured; Tyrosine | 1999 |
O-(2-[18F]fluoroethyl)-L-tyrosine and L-[methyl-11C]methionine uptake in brain tumours: initial results of a comparative study.
Topics: Adult; Aged; Brain Neoplasms; Female; Fluorine Radioisotopes; Humans; Image Interpretation, Computer-Assisted; Image Processing, Computer-Assisted; Male; Methionine; Middle Aged; Radiopharmaceuticals; Tomography, Emission-Computed; Tyrosine | 2000 |
239 other study(ies) available for tyrosine and Benign Neoplasms, Brain
Article | Year |
---|---|
18F-FET and 18F-choline PET-CT in patients with MRI-suspected low-grade gliomas: a pilot study.
Topics: Brain Neoplasms; Choline; Glioma; Humans; Magnetic Resonance Imaging; Pilot Projects; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Tyrosine | 2021 |
18F-FET PET/CT as a Diagnostic Tool for Brain Abscess.
Topics: Brain Abscess; Brain Neoplasms; Glioma; Humans; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Tyrosine | 2021 |
Topics: Brain Neoplasms; Glioma; Humans; Magnetic Resonance Imaging; Positron-Emission Tomography; Tyrosine; World Health Organization | 2022 |
Topics: Brain Neoplasms; Glioblastoma; Glioma; Humans; Magnetic Resonance Imaging; Multimodal Imaging; Positron-Emission Tomography; Retrospective Studies; Tyrosine; World Health Organization | 2021 |
Prognostic value of pre-irradiation FET PET in patients with not completely resectable IDH-wildtype glioma and minimal or absent contrast enhancement.
Topics: Adult; Aged; Brain Neoplasms; Female; Fluorine Radioisotopes; Glioma; Humans; Isocitrate Dehydrogenase; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Retrospective Studies; Tyrosine; Young Adult | 2021 |
SS-4 is a highly selective small molecule inhibitor of STAT3 tyrosine phosphorylation that potently inhibits GBM tumorigenesis in vitro and in vivo.
Topics: Apoptosis; Brain Neoplasms; Carcinogenesis; Cell Line, Tumor; Cell Proliferation; Cell Transformation, Neoplastic; Glioblastoma; Humans; Phosphorylation; STAT3 Transcription Factor; Tyrosine | 2022 |
Clinical Usefulness of 18 F-FET PET in a Pediatric Patient With Suspected Demyelinating Disease.
Topics: Brain Neoplasms; Child; Demyelinating Diseases; Humans; Magnetic Resonance Imaging; Male; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Tyrosine | 2022 |
STAT3 is a biologically relevant therapeutic target in H3K27M-mutant diffuse midline glioma.
Topics: Brain Neoplasms; Child; Glioma; Histones; Humans; Mutation; RNA, Small Interfering; STAT3 Transcription Factor; Tyrosine | 2022 |
Cost Effectiveness of
Topics: Brain Neoplasms; Cost-Benefit Analysis; Glioma; Humans; Magnetic Resonance Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Temozolomide; Tyrosine | 2022 |
Safety and Efficacy of Irradiation Boost Based on 18F-FET-PET in Patients with Newly Diagnosed Glioblastoma.
Topics: Brain Neoplasms; Glioblastoma; Humans; Necrosis; Pilot Projects; Positron-Emission Tomography; Prospective Studies; Tyrosine | 2022 |
The Value of FET PET/CT in Recurrent Glioma with a Different IDH Mutation Status: The Relationship between Imaging and Molecular Biomarkers.
Topics: Biomarkers; Brain Neoplasms; Glioma; Humans; Isocitrate Dehydrogenase; Magnetic Resonance Imaging; Mutation; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Tyrosine | 2022 |
Radiotherapy Target Volume Definition in Newly Diagnosed High-Grade Glioma Using 18F-FET PET Imaging and Multiparametric MRI: An Inter Observer Agreement Study.
Topics: Brain Neoplasms; Glioma; Humans; Multiparametric Magnetic Resonance Imaging; Observer Variation; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prospective Studies; Tomography, X-Ray Computed; Tyrosine | 2022 |
Prediction of response to lomustine-based chemotherapy in glioma patients at recurrence using MRI and FET PET.
Topics: Adult; Brain Neoplasms; Glioma; Humans; Lomustine; Magnetic Resonance Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tyrosine | 2023 |
Combination of pre-treatment dynamic [
Topics: Brain Neoplasms; Glioblastoma; Glioma; Humans; Positron-Emission Tomography; Retrospective Studies; Tyrosine | 2023 |
TSPO PET signal using [
Topics: Brain Neoplasms; Glioblastoma; Glioma; Humans; Neoplasm Recurrence, Local; Positron-Emission Tomography; Receptors, GABA; Tyrosine | 2023 |
[
Topics: Adolescent; Brain Neoplasms; Central Nervous System Neoplasms; Child; Child, Preschool; Clinical Decision-Making; Glioma; Humans; Magnetic Resonance Imaging; Male; Positron-Emission Tomography; Retrospective Studies; Tyrosine; Young Adult | 2023 |
Multimodal imaging findings in patients with glioblastoma with extensive coagulative necrosis related to regorafenib.
Topics: Brain Neoplasms; Glioblastoma; Glioma; Humans; Magnetic Resonance Imaging; Multimodal Imaging; Necrosis; Positron-Emission Tomography; Tyrosine | 2023 |
Amino Acid PET in Neurooncology.
Topics: Amino Acids; Biopsy; Brain Neoplasms; Glioblastoma; Humans; Positron-Emission Tomography; Tyrosine | 2023 |
Development of an economical method to synthesize O-(2-[
Topics: Biological Transport; Brain Neoplasms; Humans; Magnetic Resonance Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Tyrosine | 2023 |
Automated Brain Tumor Detection and Segmentation for Treatment Response Assessment Using Amino Acid PET.
Topics: Amino Acids; Brain Neoplasms; Glioma; Humans; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tyrosine | 2023 |
[The clinical impact of amino acid positron emission tomography measurements in the treatment of primary malignant brain tumors].
Topics: Adult; Brain Neoplasms; Humans; Magnetic Resonance Imaging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tyrosine | 2023 |
Predictive IDH Genotyping Based on the Evaluation of Spatial Metabolic Heterogeneity by Compartmental Uptake Characteristics in Preoperative Glioma Using
Topics: Amino Acids; Brain Neoplasms; Female; Genotype; Glioma; Humans; Isocitrate Dehydrogenase; Magnetic Resonance Imaging; Male; Positron-Emission Tomography; Tyrosine | 2023 |
Dehydroabietylamine Ureas and Thioureas as Tyrosyl-DNA Phosphodiesterase 1 Inhibitors That Enhance the Antitumor Effect of Temozolomide on Glioblastoma Cells.
Topics: Antineoplastic Agents, Alkylating; Brain Neoplasms; Cell Line, Tumor; DNA, Neoplasm; Drug Synergism; Glioblastoma; Humans; Phosphodiesterase Inhibitors; Temozolomide; Thiourea; Tyrosine; Urea | 2019 |
PTEN Suppresses Glycolysis by Dephosphorylating and Inhibiting Autophosphorylated PGK1.
Topics: Adenosine Triphosphate; Animals; Brain Neoplasms; Cell Line, Tumor; Cell Proliferation; Female; Glioblastoma; Glucose; Glycolysis; HEK293 Cells; Humans; Mice; Mice, Inbred BALB C; Mice, Nude; Phosphoglycerate Kinase; Phosphorylation; Prognosis; PTEN Phosphohydrolase; Signal Transduction; Time Factors; Tumor Burden; Tyrosine | 2019 |
Quantitative biparametric analysis of hybrid
Topics: Adult; Area Under Curve; Brain Neoplasms; Central Nervous System Neoplasms; False Positive Reactions; Female; Glioma; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Neuroimaging; Positron-Emission Tomography; Retrospective Studies; ROC Curve; Treatment Outcome; Tyrosine | 2019 |
Recurrent glioblastoma versus late posttreatment changes: diagnostic accuracy of O-(2-[18F]fluoroethyl)-L-tyrosine positron emission tomography (18F-FET PET).
Topics: Adult; Aged; Aged, 80 and over; Brain Neoplasms; Chemoradiotherapy; Combined Modality Therapy; Female; Follow-Up Studies; Glioblastoma; Humans; Immunotherapy; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Survival Rate; Tyrosine; Young Adult | 2019 |
Non-invasive tumor decoding and phenotyping of cerebral gliomas utilizing multiparametric
Topics: Brain Neoplasms; Glioma; Humans; Magnetic Resonance Imaging; Positron-Emission Tomography; Tyrosine | 2020 |
18F-FET PET for Diagnosis of Pseudoprogression of Brain Metastases in Patients With Non-Small Cell Lung Cancer.
Topics: Adult; Aged; Brain Neoplasms; Carcinoma, Non-Small-Cell Lung; Disease Progression; Female; Humans; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Retrospective Studies; Tyrosine | 2020 |
Imaging glioma biology: spatial comparison of amino acid PET, amide proton transfer, and perfusion-weighted MRI in newly diagnosed gliomas.
Topics: Amides; Amino Acids; Biology; Brain Neoplasms; Glioma; Humans; Magnetic Resonance Imaging; Perfusion; Positron-Emission Tomography; Protons; Tyrosine | 2020 |
Flare Phenomenon in
Topics: Adult; Aged; Brain Neoplasms; Female; Glioma; Humans; Male; Middle Aged; Neoplasm Grading; Positron-Emission Tomography; Preoperative Period; Tyrosine | 2020 |
Prediction of survival in patients with IDH-wildtype astrocytic gliomas using dynamic O-(2-[
Topics: Astrocytoma; Brain Neoplasms; Humans; Isocitrate Dehydrogenase; Neoplasm Grading; Positron-Emission Tomography; Retrospective Studies; Tyrosine | 2020 |
Targeting glioma-initiating cells via the tyrosine metabolic pathway.
Topics: Base Sequence; Brain Neoplasms; Cell Line, Tumor; Cells, Cultured; Chemotherapy, Adjuvant; Drug Delivery Systems; Glioma; Humans; Immunohistochemistry; Metabolic Networks and Pathways; Metabolomics; Nitrogen; Tyrosine; Tyrosine Transaminase | 2020 |
Reference values of physiological 18F-FET uptake: Implications for brain tumor discrimination.
Topics: Adolescent; Adult; Aged; Biological Transport; Brain; Brain Neoplasms; Female; Humans; Male; Middle Aged; Positron-Emission Tomography; Reference Values; Tyrosine; Young Adult | 2020 |
Radiotherapy target volume definition in newly diagnosed high grade glioma using
Topics: Brain Neoplasms; Glioma; Humans; Magnetic Resonance Angiography; Magnetic Resonance Imaging; Perfusion; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Tyrosine | 2020 |
Flare Phenomenon in
Topics: Brain Neoplasms; Glioma; Humans; Ischemia; Positron-Emission Tomography; Tyrosine | 2020 |
Reply: Flare Phenomenon in
Topics: Brain Neoplasms; Glioma; Humans; Positron-Emission Tomography; Tyrosine | 2020 |
Treatment Monitoring of Immunotherapy and Targeted Therapy Using
Topics: Adult; Aged; Aged, 80 and over; Brain Neoplasms; Combined Modality Therapy; Disease Progression; Female; Humans; Immunotherapy; Lung Neoplasms; Male; Melanoma; Middle Aged; Molecular Targeted Therapy; Retrospective Studies; Treatment Outcome; Tyrosine | 2021 |
Dual PET Imaging of an H3K27M-Mutant Glioma With 18F-GE-180 and 18F-FET PET.
Topics: Adult; Biological Transport; Biopsy; Brain Neoplasms; Carbazoles; Glioma; Histones; Humans; Male; Mutation; Positron-Emission Tomography; Tyrosine | 2020 |
Sequential implementation of DSC-MR perfusion and dynamic [
Topics: Brain Neoplasms; Glioma; Humans; Magnetic Resonance Imaging; Neoplasm Recurrence, Local; Perfusion; Positron-Emission Tomography; Retrospective Studies; Tyrosine | 2021 |
Machine learning-based differentiation between multiple sclerosis and glioma WHO II°-IV° using O-(2-[18F] fluoroethyl)-L-tyrosine positron emission tomography.
Topics: Adult; Aged; Brain Neoplasms; Female; Glioma; Humans; Image Interpretation, Computer-Assisted; Machine Learning; Male; Middle Aged; Multiple Sclerosis; Positron-Emission Tomography; Radiopharmaceuticals; Tyrosine | 2021 |
Benefit of Static FET PET in Pretreated Pediatric Brain Tumor Patients with Equivocal Conventional MRI Results.
Topics: Brain Neoplasms; Child; Humans; Infant; Magnetic Resonance Imaging; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prospective Studies; Tyrosine | 2021 |
A Linearized Fit Model for Robust Shape Parameterization of FET-PET TACs.
Topics: Adult; Brain Neoplasms; Glioma; Humans; Kinetics; Positron-Emission Tomography; Tyrosine | 2021 |
18F-FET PET/CT in Early Subventricular Zone Recurrence of Adult Glioblastoma.
Topics: Adult; Brain Neoplasms; Female; Glioblastoma; Humans; Lateral Ventricles; Positron Emission Tomography Computed Tomography; Recurrence; Tyrosine | 2021 |
Intracellular Progesterone Receptor and cSrc Protein Working Together to Regulate the Activity of Proteins Involved in Migration and Invasion of Human Glioblastoma Cells.
Topics: Brain Neoplasms; Cell Line, Tumor; Cell Movement; Cell Proliferation; CSK Tyrosine-Protein Kinase; Focal Adhesion Protein-Tyrosine Kinases; Focal Adhesions; Glioblastoma; Humans; Neoplasm Invasiveness; Paxillin; Phosphorylation; Progesterone; Protein-Tyrosine Kinases; Receptors, Progesterone; RNA, Small Interfering; Signal Transduction; Tyrosine | 2021 |
Diagnostic accuracy and clinical impact of [18F]FET PET in childhood CNS tumors.
Topics: Adult; Brain Neoplasms; Child; Glioma; Humans; Magnetic Resonance Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Tyrosine | 2021 |
Multimodal assessment of disease activity in glioblastoma : A single center experience.
Topics: Brain Neoplasms; Glioblastoma; Humans; Magnetic Resonance Imaging; Pilot Projects; Positron-Emission Tomography; Retrospective Studies; Tyrosine | 2021 |
Diagnosis of Pseudoprogression Following Lomustine-Temozolomide Chemoradiation in Newly Diagnosed Glioblastoma Patients Using FET-PET.
Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Chemoradiotherapy; Disease Progression; Female; Glioblastoma; Humans; Lomustine; Male; Middle Aged; Positron-Emission Tomography; Retrospective Studies; Temozolomide; Tyrosine | 2021 |
A Phase 0 Microdosing PET/CT Study Using O-[18F]Fluoromethyl-d-Tyrosine in Normal Human Brain and Brain Tumor.
Topics: Adult; Brain; Brain Neoplasms; Female; Humans; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Tyrosine; Young Adult | 2021 |
Fluorescence real-time kinetics of protoporphyrin IX after 5-ALA administration in low-grade glioma.
Topics: Adult; Aminolevulinic Acid; Brain Neoplasms; Chromosome Deletion; Female; Fluorescence; Glioma; Humans; Ki-67 Antigen; Magnetic Resonance Imaging; Male; Middle Aged; Photosensitizing Agents; Positron-Emission Tomography; Protoporphyrins; Radiopharmaceuticals; Spectrometry, Fluorescence; Tyrosine | 2022 |
Selective resection of cushing microadenoma guided by preoperative hybrid 18-fluoroethyl-L-tyrosine and 11-C-methionine PET/MRI.
Topics: Adenoma; Brain Neoplasms; Cohort Studies; Humans; Magnetic Resonance Imaging; Methionine; Middle Aged; Positron-Emission Tomography; Retrospective Studies; Tyrosine | 2021 |
Determination of an Optimal Pharmacokinetic Model of
Topics: Animals; Brain Neoplasms; Kinetics; Male; Models, Biological; Positron-Emission Tomography; Rats; Tissue Distribution; Tyrosine | 2017 |
Utilizing 18F-fluoroethyl-l-tyrosine positron emission tomography in high grade glioma for radiation treatment planning in patients with contraindications to MRI.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Brain Neoplasms; Combined Modality Therapy; Female; Glioma; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Treatment Outcome; Tyrosine | 2018 |
Identification of time-to-peak on dynamic 18F-FET-PET as a prognostic marker specifically in IDH1/2 mutant diffuse astrocytoma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Astrocytoma; Brain Neoplasms; Child; Chromosomes, Human, Pair 19; Female; Humans; Isocitrate Dehydrogenase; Male; Middle Aged; Mutation; Positron-Emission Tomography; Prognosis; Time Factors; Tyrosine; Young Adult | 2018 |
AIDS-Related Central Nervous System Toxoplasmosis With Increased 18F-Fluoroethyl-L-Tyrosine Amino Acid PET Uptake Due to LAT1/2 Expression of Inflammatory Cells.
Topics: Acquired Immunodeficiency Syndrome; Adaptor Proteins, Signal Transducing; Adult; Biological Transport; Brain Neoplasms; Diagnosis, Differential; Female; Gene Expression Regulation; Humans; Inflammation; Large Neutral Amino Acid-Transporter 1; Positron-Emission Tomography; Toxoplasmosis, Cerebral; Tyrosine | 2017 |
Evaluation of factors influencing
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Body Mass Index; Brain; Brain Neoplasms; Female; Humans; Male; Middle Aged; Positron-Emission Tomography; Reference Standards; Retrospective Studies; Sex Factors; Tyrosine; Young Adult | 2018 |
Radiosynthesis and modified quality control of O-(2-[
Topics: Brain Neoplasms; Equipment Design; Fluorine Radioisotopes; Humans; Positron-Emission Tomography; Quality Control; Radiopharmaceuticals; Technology, Radiologic; Tyrosine | 2018 |
Hybrid MR-PET of brain tumours using amino acid PET and chemical exchange saturation transfer MRI.
Topics: Adult; Aged; Brain Neoplasms; Female; Glioma; Humans; Male; Middle Aged; Proton Magnetic Resonance Spectroscopy; Protons; Tyrosine; Young Adult | 2018 |
Use of FET PET in glioblastoma patients undergoing neurooncological treatment including tumour-treating fields: initial experience.
Topics: Adult; Aged; Brain Neoplasms; Female; Glioblastoma; Glioma; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tyrosine | 2018 |
The diagnostic accuracy of detecting malignant transformation of low-grade glioma using O-(2-[18F]fluoroethyl)-l-tyrosine positron emission tomography: a retrospective study.
Topics: Adult; Biomarkers, Tumor; Brain Neoplasms; Cell Transformation, Neoplastic; Female; Glioma; Humans; Immunohistochemistry; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Grading; Oligodendroglia; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; ROC Curve; Sensitivity and Specificity; Treatment Outcome; Tyrosine | 2018 |
O-(2-(
Topics: Adult; Aged; Brain Neoplasms; Diagnosis, Differential; Female; Glioblastoma; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Retrospective Studies; Tyrosine; Young Adult | 2019 |
Recurrent pseudoprogression in isocitrate dehydrogenase 1 mutant glioblastoma.
Topics: Aged; Brain Neoplasms; Chemoradiotherapy; Disease Progression; Glioblastoma; Humans; Isocitrate Dehydrogenase; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tyrosine | 2018 |
Diagnosis of glioma recurrence using multiparametric dynamic 18F-fluoroethyl-tyrosine PET-MRI.
Topics: Brain Neoplasms; Female; Fluorine Radioisotopes; Glioma; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tyrosine; Vinyl Compounds | 2018 |
Correlation of Dynamic O-(2-[
Topics: Brain; Brain Neoplasms; Combined Modality Therapy; Fatal Outcome; Glioblastoma; Humans; Magnetic Resonance Imaging; Middle Aged; Neuroimaging; Positron-Emission Tomography; Radiopharmaceuticals; Tyrosine | 2018 |
[
Topics: Administration, Intravenous; Animals; Brain Neoplasms; Disease Models, Animal; Glioma; Heterografts; Histocytochemistry; Luminescent Measurements; Neoplasm Transplantation; Rats; Surgery, Computer-Assisted; Treatment Outcome; Tyrosine | 2018 |
Combined FET PET/MRI radiomics differentiates radiation injury from recurrent brain metastasis.
Topics: Adolescent; Adult; Aged; Brain Neoplasms; Female; Fluorine Radioisotopes; Follow-Up Studies; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiation Injuries; Tyrosine; Vinyl Compounds; Young Adult | 2018 |
Neurosarcoidosis Mimics High-Grade Glioma in Dynamic 18F-FET PET Due to LAT Expression.
Topics: Brain Neoplasms; Central Nervous System Diseases; Diagnosis, Differential; Glioma; Humans; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Sarcoidosis; Tyrosine | 2018 |
Diffusion-weighted MRI and ADC versus FET-PET and GdT1w-MRI for gross tumor volume (GTV) delineation in re-irradiation of recurrent glioblastoma.
Topics: Adult; Aged; Brain Neoplasms; Diffusion Magnetic Resonance Imaging; Female; Glioblastoma; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prospective Studies; Radiosurgery; Re-Irradiation; Tumor Burden; Tyrosine | 2019 |
Can Early Postoperative O-(2-
Topics: Adult; Aged; Aged, 80 and over; Brain Neoplasms; Electroencephalography; Evoked Potentials, Somatosensory; Female; Follow-Up Studies; Glioblastoma; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Predictive Value of Tests; Retrospective Studies; Tomography Scanners, X-Ray Computed; Tyrosine | 2019 |
Feasibility and robustness of dynamic
Topics: Aged; Antineoplastic Agents; Brain Neoplasms; Carbon; Female; Glioma; Heavy Ion Radiotherapy; Humans; Image Interpretation, Computer-Assisted; Male; Middle Aged; Models, Statistical; Neoplasm Grading; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Survival Analysis; Temozolomide; Tyrosine | 2018 |
Role of
Topics: Brain Neoplasms; Disease Management; Female; Follow-Up Studies; Glioma; Humans; Male; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tyrosine | 2019 |
FET PET reveals considerable spatial differences in tumour burden compared to conventional MRI in newly diagnosed glioblastoma.
Topics: Adult; Aged; Brain Neoplasms; Female; Glioblastoma; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Tumor Burden; Tyrosine | 2019 |
Characterization of Diffuse Gliomas With Histone H3-G34 Mutation by MRI and Dynamic 18F-FET PET.
Topics: Adolescent; Adult; Brain Neoplasms; Child; Female; Glioma; Histones; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Mutation; Positron-Emission Tomography; Radiopharmaceuticals; Tyrosine | 2018 |
A Novel Venom-Derived Peptide for Brachytherapy of Glioblastoma: Preclinical Studies in Mice.
Topics: Animals; Brachytherapy; Brain Neoplasms; Cell Proliferation; Cell Survival; Disintegrins; Drug Synergism; Glioblastoma; Humans; Iodine Radioisotopes; Mice; Recombinant Proteins; Snake Venoms; Temozolomide; Tyrosine; Xenograft Model Antitumor Assays | 2018 |
Influence of volumetric modulated arc therapy and FET-PET scanning on treatment outcomes for glioblastoma patients.
Topics: Adult; Brain Neoplasms; Glioblastoma; Humans; Middle Aged; Positron-Emission Tomography; Proportional Hazards Models; Radiotherapy, Intensity-Modulated; Treatment Outcome; Tumor Burden; Tyrosine | 2019 |
Monitoring Treatment Response to Erlotinib in EGFR-mutated Non-small-cell Lung Cancer Brain Metastases Using Serial O-(2-[
Topics: Adult; Antineoplastic Agents; Brain Neoplasms; Carcinoma, Non-Small-Cell Lung; ErbB Receptors; Erlotinib Hydrochloride; Female; Humans; Lung Neoplasms; Mutation; Positron-Emission Tomography; Tyrosine | 2019 |
In Reply to Letter to the Editor Regarding "Can Early Postoperative O-(2-
Topics: Adult; Brain Neoplasms; Glioblastoma; Humans; Neoplasm Recurrence, Local; Positron-Emission Tomography; Tyrosine | 2019 |
Inhibition of Nuclear PTEN Tyrosine Phosphorylation Enhances Glioma Radiation Sensitivity through Attenuated DNA Repair.
Topics: Animals; Brain Neoplasms; Cell Nucleus; DNA Repair; Female; Glioma; Humans; Male; Mice; Phosphorylation; PTEN Phosphohydrolase; Pyrimidines; Rad51 Recombinase; Radiation Tolerance; Receptor, Fibroblast Growth Factor, Type 2; Tyrosine; Xenograft Model Antitumor Assays | 2019 |
Letter to the Editor Regarding "Can Early Postoperative O-(2-
Topics: Adult; Brain Neoplasms; Glioblastoma; Humans; Neoplasm Recurrence, Local; Positron-Emission Tomography; Tyrosine | 2019 |
Personalized Radiotherapy Design for Glioblastoma: Integrating Mathematical Tumor Models, Multimodal Scans, and Bayesian Inference.
Topics: Bayes Theorem; Brain; Brain Neoplasms; Glioblastoma; Humans; Multimodal Imaging; Positron-Emission Tomography; Precision Medicine; Radiotherapy Planning, Computer-Assisted; Tyrosine | 2019 |
Prognostic Value of O-(2-[
Topics: Brain Neoplasms; Female; Glioma; Humans; Male; Middle Aged; Neoplasm Grading; Positron Emission Tomography Computed Tomography; Prognosis; Progression-Free Survival; Tyrosine; World Health Organization | 2019 |
Comparison of [
Topics: Adult; Brain Neoplasms; Cohort Studies; Female; Fluorine Radioisotopes; Glioma; Humans; Isocitrate Dehydrogenase; Magnetic Resonance Imaging; Male; Middle Aged; Pilot Projects; Positron-Emission Tomography; Radiopharmaceuticals; Tumor Burden; Tyrosine | 2020 |
Photopenic defects on O-(2-[18F]-fluoroethyl)-L-tyrosine PET: clinical relevance in glioma patients.
Topics: Adolescent; Adult; Aged; Brain Neoplasms; Female; Glioma; Humans; Male; Middle Aged; Neuroimaging; Positron-Emission Tomography; Progression-Free Survival; Radiopharmaceuticals; Retrospective Studies; Tyrosine; Young Adult | 2019 |
Quantitative parametric maps of O-(2-[
Topics: Adult; Aged; Brain Mapping; Brain Neoplasms; Fluorine Radioisotopes; Glioma; Humans; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Tissue Distribution; Tyrosine; Young Adult | 2020 |
Technical feasibility of [
Topics: Animals; Brain Neoplasms; Cell Line, Tumor; Disease Models, Animal; Feasibility Studies; Female; Glioblastoma; Nitroimidazoles; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Dosage; Radiotherapy, Image-Guided; Rats, Inbred F344; Treatment Outcome; Tumor Burden; Tyrosine | 2019 |
5-Aminolevulinic Acid Fluorescence-Guided Resection of 18F-FET-PET Positive Tumor Beyond Gadolinium Enhancing Tumor Improves Survival in Glioblastoma.
Topics: Aminolevulinic Acid; Brain Neoplasms; Gadolinium; Glioblastoma; Humans; Optical Imaging; Positron-Emission Tomography; Tyrosine | 2019 |
Clinical Utility of Different Approaches for Detection of Late Pseudoprogression in Glioblastoma With O-(2-[18F]Fluoroethyl)-L-Tyrosine PET.
Topics: Adult; Aged; Brain Neoplasms; Disease Progression; Female; Glioblastoma; Humans; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Retrospective Studies; ROC Curve; Tyrosine; Young Adult | 2019 |
Hypometabolic gliomas on FET-PET-is there an inverted U-curve for survival?
Topics: Brain Neoplasms; Glioma; Humans; Positron-Emission Tomography; Tyrosine | 2019 |
Dynamic FET PET Imaging of a "Butterfly" IDH-Wildtype Anaplastic Astrocytoma.
Topics: Aged; Astrocytoma; Brain Neoplasms; Humans; Isocitrate Dehydrogenase; Magnetic Resonance Imaging; Male; Positron-Emission Tomography; Tyrosine | 2019 |
Being sensitive: to specify when amino acid tracers accumulate in a brain lesion.
Topics: Brain Neoplasms; Female; Glioma; Humans; Male; Positron-Emission Tomography; Tyrosine | 2013 |
18F-AFETP, 18F-FET, and 18F-FDG imaging of mouse DBT gliomas.
Topics: Alanine; Animals; Brain Neoplasms; Cell Line, Tumor; Fluorodeoxyglucose F18; Glioma; Male; Metabolic Clearance Rate; Mice; Mice, Inbred BALB C; Organ Specificity; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tissue Distribution; Triazoles; Tyrosine | 2013 |
Reply to "[18F]-fluoro-ethyl-L-tyrosine PET: a valuable diagnostic tool in neuro-oncology, but not all that glitters is glioma" by Hutterer et al.
Topics: Brain Neoplasms; Female; Fluorodeoxyglucose F18; Glioma; Humans; Male; Positron-Emission Tomography; Radiopharmaceuticals; Tyrosine | 2013 |
Replay: being sensitive: to specify when amino acid tracers accumulate in a brain lesion.
Topics: Brain Neoplasms; Female; Glioma; Humans; Male; Positron-Emission Tomography; Tyrosine | 2013 |
Uptake of O-(2-[18F]fluoroethyl)-L-tyrosine in reactive astrocytosis in the vicinity of cerebral gliomas.
Topics: Animals; Biological Transport; Brain; Brain Neoplasms; Cell Line, Tumor; False Positive Reactions; Glioma; Gliosis; Male; Positron-Emission Tomography; Rats; Tyrosine | 2013 |
The use of O-(2-18F-fluoroethyl)-L-tyrosine PET for treatment management of bevacizumab and irinotecan in patients with recurrent high-grade glioma: a cost-effectiveness analysis.
Topics: Antibodies, Monoclonal, Humanized; Bevacizumab; Brain Neoplasms; Camptothecin; Cost-Benefit Analysis; Decision Trees; Disease-Free Survival; Glioma; Humans; Irinotecan; Magnetic Resonance Imaging; Monte Carlo Method; Neoplasm Grading; Positron-Emission Tomography; Recurrence; Treatment Outcome; Tyrosine | 2013 |
Response to "reply to [18F]-fluoro-ethyl-L-tyrosine PET: a valuable diagnostic tool in neuro-oncology, but not all that glitters is glioma" by Hutterer et al.
Topics: Brain Neoplasms; Female; Fluorodeoxyglucose F18; Glioma; Humans; Male; Positron-Emission Tomography; Radiopharmaceuticals; Tyrosine | 2013 |
Analysis of FET-PET imaging for target volume definition in patients with gliomas treated with conformal radiotherapy.
Topics: Adult; Aged; Brain Neoplasms; Female; Glioma; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Conformal; Radiotherapy, Intensity-Modulated; Tomography, X-Ray Computed; Tyrosine; Young Adult | 2013 |
Combined molecular MRI and immuno-spin-trapping for in vivo detection of free radicals in orthotopic mouse GL261 gliomas.
Topics: Albumins; Animals; Brain Neoplasms; Contrast Media; Cyclic N-Oxides; Disease Models, Animal; Free Radicals; Gadolinium DTPA; Glioma; Immunoglobulin G; Magnetic Resonance Imaging; Mice; Mice, Inbred C57BL; Nitrogen Oxides; Oxidation-Reduction; Radiography; Spin Labels; Spin Trapping; Tumor Cells, Cultured; Tyrosine | 2013 |
Monitoring of radiochemotherapy in patients with glioblastoma using O-(2-¹⁸Fluoroethyl)-L-tyrosine positron emission tomography: is dynamic imaging helpful?
Topics: Adult; Aged; Area Under Curve; Brain Neoplasms; Female; Fluorine Radioisotopes; Glioblastoma; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Tyrosine | 2013 |
Synthesis and evaluation of ¹⁸F labeled FET prodrugs for tumor imaging.
Topics: Amidohydrolases; Animals; Biological Transport; Brain Neoplasms; Cell Line, Tumor; Chemistry Techniques, Synthetic; Dipeptidases; Humans; Hydrolysis; Positron-Emission Tomography; Prodrugs; Rats; Tyrosine | 2014 |
Discriminating ability of (18)F-FET PET for several cerebral neoplastic lesions.
Topics: Brain Neoplasms; Female; Glioma; Humans; Male; Positron-Emission Tomography; Tyrosine | 2014 |
Reply: discriminating ability of (18)F-FET PET for several cerebral neoplastic lesions.
Topics: Brain Neoplasms; Female; Glioma; Humans; Male; Positron-Emission Tomography; Tyrosine | 2014 |
Relationship of regional cerebral blood flow and kinetic behaviour of O-(2-(18)F-fluoroethyl)-L-tyrosine uptake in cerebral gliomas.
Topics: Adult; Aged; Biological Transport; Brain Neoplasms; Cerebrovascular Circulation; Female; Glioma; Humans; Kinetics; Male; Middle Aged; Positron-Emission Tomography; Tyrosine | 2014 |
O-(2-[(18)F]fluoroethyl)-L-tyrosine uptake is an independent prognostic determinant in patients with glioma referred for radiation therapy.
Topics: Adolescent; Adult; Aged; Brain; Brain Neoplasms; Disease-Free Survival; Female; Glioma; Humans; Kaplan-Meier Estimate; Magnetic Resonance Imaging; Male; Middle Aged; Multivariate Analysis; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Time Factors; Tyrosine; Young Adult | 2014 |
Intra-individual comparison of ¹⁸F-FET and ¹⁸F-DOPA in PET imaging of recurrent brain tumors.
Topics: Astrocytoma; Brain Neoplasms; Dihydroxyphenylalanine; Glioblastoma; Humans; Neoplasm Recurrence, Local; Positron-Emission Tomography; Tyrosine | 2014 |
Dynamic 18F-FET PET in newly diagnosed astrocytic low-grade glioma identifies high-risk patients.
Topics: Adult; Astrocytes; Brain Neoplasms; Disease Progression; Disease-Free Survival; Female; Glioma; Humans; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Risk; Time Factors; Treatment Outcome; Tyrosine | 2014 |
Focal changes in diffusivity on apparent diffusion coefficient MR imaging and amino acid uptake on PET do not colocalize in nonenhancing low-grade gliomas.
Topics: Adult; Aged; Amino Acids; Brain Neoplasms; Cerebellar Neoplasms; Cerebellum; Diffusion; Diffusion Magnetic Resonance Imaging; Female; Glioma; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tyrosine | 2014 |
Osthole suppresses the migratory ability of human glioblastoma multiforme cells via inhibition of focal adhesion kinase-mediated matrix metalloproteinase-13 expression.
Topics: Blotting, Western; Brain Neoplasms; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Cnidium; Coumarins; Dose-Response Relationship, Drug; Down-Regulation; Focal Adhesion Protein-Tyrosine Kinases; Fruit; Glioblastoma; Humans; Matrix Metalloproteinase 13; Phosphorylation; Tyrosine | 2014 |
Multimodal imaging in cerebral gliomas and its neuropathological correlation.
Topics: Adult; Aged; Aged, 80 and over; Algorithms; Brain Neoplasms; Diagnosis, Differential; Female; Glioma; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tyrosine; Young Adult | 2014 |
Combination of MRI and dynamic FET PET for initial glioma grading.
Topics: Adult; Brain Neoplasms; Female; Glioma; Humans; Image Enhancement; Magnetic Resonance Imaging; Male; Multimodal Imaging; Neoplasm Grading; Observer Variation; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tyrosine | 2014 |
Profilin-1 phosphorylation directs angiocrine expression and glioblastoma progression through HIF-1α accumulation.
Topics: Animals; Autocrine Communication; Brain Neoplasms; Capillary Permeability; Cell Line, Tumor; Cell Proliferation; Disease Models, Animal; Disease Progression; Endothelial Cells; Female; Glioblastoma; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Mutation; Neoplasm Grading; Neovascularization, Pathologic; Phosphorylation; Profilins; RNA Interference; Time Factors; Transfection; Tumor Burden; Tumor Microenvironment; Tyrosine; Up-Regulation; Von Hippel-Lindau Tumor Suppressor Protein | 2014 |
The use of longitudinal 18F-FET MicroPET imaging to evaluate response to irinotecan in orthotopic human glioblastoma multiforme xenografts.
Topics: Animals; Antineoplastic Agents, Phytogenic; Brain; Brain Neoplasms; Camptothecin; Cell Line, Tumor; Female; Glioblastoma; Heterografts; Humans; Irinotecan; Mice, Nude; Neuroimaging; Positron-Emission Tomography; Tyrosine | 2014 |
Prediction of glioma recurrence using dynamic ¹⁸F-fluoroethyltyrosine PET.
Topics: Adult; Aged; Brain Neoplasms; Disease Progression; Disease-Free Survival; Female; Glioma; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Retrospective Studies; Tyrosine | 2014 |
FET-PET-based reirradiation and chloroquine in patients with recurrent glioblastoma: first tolerability and feasibility results.
Topics: Adult; Brain Neoplasms; Chloroquine; Feasibility Studies; Female; Glioblastoma; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Pilot Projects; Positron-Emission Tomography; Radiation-Sensitizing Agents; Radiopharmaceuticals; Radiotherapy Dosage; Radiotherapy, Image-Guided; Treatment Outcome; Tyrosine | 2014 |
Comparison of the amino acid tracers 18F-FET and 18F-DOPA in high-grade glioma patients.
Topics: Adult; Aged; Aged, 80 and over; Amino Acids; Basal Ganglia; Biopsy; Brain; Brain Neoplasms; Dihydroxyphenylalanine; Female; Glioma; Humans; Logistic Models; Male; Middle Aged; Prospective Studies; Radionuclide Imaging; Recurrence; Tyrosine | 2014 |
(18)F-fluoromethylcholine (FCho), (18)F-fluoroethyltyrosine (FET), and (18)F-fluorodeoxyglucose (FDG) for the discrimination between high-grade glioma and radiation necrosis in rats: a PET study.
Topics: Animals; Brain Neoplasms; Cell Line, Tumor; Choline; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Glioblastoma; Necrosis; Neoplasm Grading; Positron-Emission Tomography; Radiation Injuries; Radioactive Tracers; Radiopharmaceuticals; Rats; Recurrence; Tyrosine | 2015 |
(18)F-FET-PET guided surgical biopsy and resection in children and adolescence with brain tumors.
Topics: Adolescent; Brain Neoplasms; Child; Child, Preschool; Female; Humans; Infant; Male; Neuronavigation; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tyrosine | 2015 |
Diagnosis of pseudoprogression in patients with glioblastoma using O-(2-[18F]fluoroethyl)-L-tyrosine PET.
Topics: Adult; Aged; Brain Neoplasms; Disease Progression; False Positive Reactions; Female; Glioblastoma; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Tyrosine | 2015 |
The usefulness of dynamic O-(2-18F-fluoroethyl)-L-tyrosine PET in the clinical evaluation of brain tumors in children and adolescents.
Topics: Adolescent; Brain Neoplasms; Child; Child, Preschool; Disease Progression; Female; Humans; Infant; Male; Neoplasm, Residual; Positron-Emission Tomography; Recurrence; Sensitivity and Specificity; Tyrosine | 2015 |
Impact of [18F]-fluoro-ethyl-tyrosine PET imaging on target definition for radiation therapy of high-grade glioma.
Topics: Adult; Aged; Aged, 80 and over; Brain Neoplasms; Glioma; Humans; Magnetic Resonance Imaging; Middle Aged; Neoplasm Grading; Positron-Emission Tomography; Tyrosine; Young Adult | 2015 |
Biological tumor volume in 18FET-PET before radiochemotherapy correlates with survival in GBM.
Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Brain; Brain Neoplasms; Chemoradiotherapy; Combined Modality Therapy; Dacarbazine; Disease-Free Survival; Female; Glioblastoma; Humans; Longitudinal Studies; Male; Microsurgery; Middle Aged; Neurosurgical Procedures; Positron-Emission Tomography; Prospective Studies; Temozolomide; Treatment Outcome; Tumor Burden; Tyrosine | 2015 |
18F-FET microPET and microMRI for anti-VEGF and anti-PlGF response assessment in an orthotopic murine model of human glioblastoma.
Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Cell Line, Tumor; Cell Transformation, Neoplastic; Drug Synergism; Female; Gene Expression Regulation, Neoplastic; Glioblastoma; Humans; Magnetic Resonance Imaging; Membrane Proteins; Mice; Microvessels; Multimodal Imaging; Optical Imaging; Positron-Emission Tomography; RNA, Messenger; Survival Analysis; Tomography, X-Ray Computed; Treatment Outcome; Tyrosine; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-1 | 2015 |
18F-fluoro-ethyl-tyrosine positron emission tomography for grading and estimation of prognosis in patients with intracranial gliomas.
Topics: Adult; Aged; Area Under Curve; Brain Neoplasms; Female; Follow-Up Studies; Glioma; Humans; Male; Middle Aged; Neoplasm Grading; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; ROC Curve; Tyrosine | 2015 |
Dual-time-point O-(2-[(18)F]fluoroethyl)-L-tyrosine PET for grading of cerebral gliomas.
Topics: Adult; Aged; Brain Neoplasms; Female; Glioma; Humans; Male; Middle Aged; Neoplasm Grading; Physical Examination; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tyrosine | 2015 |
The use of dynamic O-(2-18F-fluoroethyl)-l-tyrosine PET in the diagnosis of patients with progressive and recurrent glioma.
Topics: Brain Neoplasms; Disease Progression; Female; Glioma; Humans; Male; Middle Aged; Positron-Emission Tomography; Retrospective Studies; Sensitivity and Specificity; Tyrosine | 2015 |
TSPO Imaging in Glioblastoma Multiforme: A Direct Comparison Between 123I-CLINDE SPECT, 18F-FET PET, and Gadolinium-Enhanced MR Imaging.
Topics: Aged; Biomarkers, Tumor; Brain Neoplasms; Bridged Bicyclo Compounds, Heterocyclic; Female; Fluorodeoxyglucose F18; Gadolinium; Glioblastoma; Humans; Image Interpretation, Computer-Assisted; Magnetic Resonance Imaging; Male; Middle Aged; Molecular Imaging; Radiopharmaceuticals; Receptors, GABA; Reproducibility of Results; Sensitivity and Specificity; Tissue Distribution; Tomography, Emission-Computed; Tyrosine | 2015 |
Textural analysis of pre-therapeutic [18F]-FET-PET and its correlation with tumor grade and patient survival in high-grade gliomas.
Topics: Brain Neoplasms; Female; Glioma; Humans; Male; Middle Aged; Neoplasm Grading; Positron-Emission Tomography; Retrospective Studies; Survival Analysis; Tumor Burden; Tyrosine | 2016 |
Volumetric Analysis of F-18-FET-PET Imaging for Brain Metastases.
Topics: Adult; Aged; Brain Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Tumor Burden; Tyrosine | 2015 |
Simultaneous evaluation of brain tumour metabolism, structure and blood volume using [(18)F]-fluoroethyltyrosine (FET) PET/MRI: feasibility, agreement and initial experience.
Topics: Blood Volume; Brain Neoplasms; Feasibility Studies; Glioma; Humans; Magnetic Resonance Imaging; Multimodal Imaging; Positron-Emission Tomography; Retrospective Studies; Time Factors; Tumor Burden; Tyrosine | 2016 |
The Value of 5-Aminolevulinic Acid in Low-grade Gliomas and High-grade Gliomas Lacking Glioblastoma Imaging Features: An Analysis Based on Fluorescence, Magnetic Resonance Imaging, 18F-Fluoroethyl Tyrosine Positron Emission Tomography, and Tumor Molecular
Topics: Aged; Aminolevulinic Acid; Brain Neoplasms; Chromosome Deletion; Chromosomes, Human, Pair 1; Female; Fluorescence; Glioblastoma; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Grading; O(6)-Methylguanine-DNA Methyltransferase; Positron-Emission Tomography; Radiopharmaceuticals; Tyrosine | 2016 |
Nitroproteins in Human Astrocytomas Discovered by Gel Electrophoresis and Tandem Mass Spectrometry.
Topics: Adolescent; Adult; Aged; Amino Acid Sequence; Astrocytoma; Blotting, Western; Brain; Brain Chemistry; Brain Neoplasms; Electrophoresis, Gel, Two-Dimensional; Female; Humans; Male; Middle Aged; Molecular Sequence Data; Proteins; Tandem Mass Spectrometry; Tyrosine | 2015 |
Reproducibility of O-(2-(18)F-fluoroethyl)-L-tyrosine uptake kinetics in brain tumors and influence of corticoid therapy: an experimental study in rat gliomas.
Topics: Animals; Biological Transport; Brain Neoplasms; Dexamethasone; Disease Models, Animal; Glioma; Kinetics; Male; Positron-Emission Tomography; Rats; Reproducibility of Results; Tyrosine | 2016 |
Late Pseudoprogression in Glioblastoma: Diagnostic Value of Dynamic O-(2-[18F]fluoroethyl)-L-Tyrosine PET.
Topics: Adult; Aged; Brain Neoplasms; Chemoradiotherapy; Disease Progression; Female; Glioblastoma; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tyrosine; Young Adult | 2016 |
Prognostic Value of O-(2-[18F]-Fluoroethyl)-L-Tyrosine-Positron Emission Tomography Imaging for Histopathologic Characteristics and Progression-Free Survival in Patients with Low-Grade Glioma.
Topics: Adult; Biomarkers, Tumor; Brain; Brain Neoplasms; Disease-Free Survival; Female; Glioma; Humans; Kaplan-Meier Estimate; Magnetic Resonance Imaging; Male; Neoplasm Grading; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tumor Burden; Tyrosine | 2016 |
Pilot Preclinical and Clinical Evaluation of (4S)-4-(3-[18F]Fluoropropyl)-L-Glutamate (18F-FSPG) for PET/CT Imaging of Intracranial Malignancies.
Topics: Adult; Aged; Animals; Brain Neoplasms; Case-Control Studies; Cell Line, Tumor; Disease Models, Animal; Female; Fluorodeoxyglucose F18; Glioblastoma; Glutamic Acid; Heterografts; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Rats; Tomography, X-Ray Computed; Tyrosine | 2016 |
(18)F-Fluoroethyl-l-Thyrosine Positron Emission Tomography to Delineate Tumor Residuals After Glioblastoma Resection: A Comparison with Standard Postoperative Magnetic Resonance Imaging.
Topics: Adult; Aged; Aged, 80 and over; Brain; Brain Neoplasms; Female; Glioblastoma; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm, Residual; Positron-Emission Tomography; Postoperative Period; Preoperative Period; Radiopharmaceuticals; Sensitivity and Specificity; Time Factors; Tyrosine | 2016 |
Comparison of (18)F-FET and (18)F-FLT small animal PET for the assessment of anti-VEGF treatment response in an orthotopic model of glioblastoma.
Topics: Animals; Bevacizumab; Brain Neoplasms; Cell Transformation, Neoplastic; Dideoxynucleosides; Female; Glioblastoma; HEK293 Cells; Humans; Mice; Microvessels; Positron-Emission Tomography; Survival Analysis; Tyrosine; Vascular Endothelial Growth Factor A | 2016 |
Effect of α-Methyl versus α-Hydrogen Substitution on Brain Availability and Tumor Imaging Properties of Heptanoic [F-18]Fluoroalkyl Amino Acids for Positron Emission Tomography (PET).
Topics: Amino Acid Substitution; Amino Acids; Amino Acids, Neutral; Animals; Biological Transport; Brain; Brain Neoplasms; Fluorine Radioisotopes; Glioma; Hydrogen; Male; Methylation; Mice; Mice, Inbred BALB C; Positron-Emission Tomography; Radiopharmaceuticals; Tissue Distribution; Tyrosine | 2016 |
Serial 18F-FET PET Imaging of Primarily 18F-FET-Negative Glioma: Does It Make Sense?
Topics: Adult; Aged; Brain Neoplasms; Diagnosis, Differential; False Negative Reactions; Female; Glioma; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Tyrosine; Watchful Waiting; Young Adult | 2016 |
Response to: Performance of 18F-FET-PET versus 18F-FDG-PET for the diagnosis and grading of brain tumors: inherent bias in meta-analysis not revealed by quality metrics.
Topics: Bias; Brain Neoplasms; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Radiopharmaceuticals; Tyrosine | 2016 |
Performance of 18F-FET-PET versus 18F-FDG-PET for the diagnosis and grading of brain tumors: inherent bias in meta-analysis not revealed by quality metrics.
Topics: Bias; Brain Neoplasms; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Radiopharmaceuticals; Tyrosine | 2016 |
Connexin43 recruits PTEN and Csk to inhibit c-Src activity in glioma cells and astrocytes.
Topics: Animals; Astrocytes; Brain Neoplasms; Cell Line, Tumor; Cell Proliferation; Cells, Cultured; Connexin 43; CSK Tyrosine-Protein Kinase; Gene Expression Regulation, Neoplastic; Glioma; Humans; Neoplastic Stem Cells; Phosphorylation; Prosencephalon; Protein Domains; Proto-Oncogene Mas; Proto-Oncogene Proteins pp60(c-src); PTEN Phosphohydrolase; Rats; Rats, Wistar; src-Family Kinases; Tyrosine | 2016 |
L-Tyrosine Confers Residualizing Properties to a d-Amino Acid-Rich Residualizing Peptide for Radioiodination of Internalizing Antibodies.
Topics: Animals; Antibodies, Monoclonal; Brain Neoplasms; Cell Line, Tumor; Glioblastoma; Humans; Iodine Radioisotopes; Mice; Neoplasm Transplantation; Peptides; Radiopharmaceuticals; Tissue Distribution; Tyrosine | 2016 |
Epileptic Activity Increases Cerebral Amino Acid Transport Assessed by 18F-Fluoroethyl-l-Tyrosine Amino Acid PET: A Potential Brain Tumor Mimic.
Topics: Adult; Aged; Amino Acid Transport Systems; Amino Acids; Biological Transport, Active; Brain Neoplasms; Diagnosis, Differential; Diagnostic Errors; Epilepsy; Female; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tyrosine | 2017 |
Dynamic O-(2-18F-fluoroethyl)-L-tyrosine positron emission tomography differentiates brain metastasis recurrence from radiation injury after radiotherapy.
Topics: Adolescent; Adult; Aged; Brain Neoplasms; Diagnosis, Differential; Disease Progression; Female; Follow-Up Studies; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiation Injuries; Radiopharmaceuticals; Radiotherapy; Tyrosine; Young Adult | 2017 |
Strategy based on kinetics of O-(2-[
Topics: Brain Neoplasms; Computer Simulation; Glioma; Humans; Image Enhancement; Models, Biological; Neoplasm Grading; Reproducibility of Results; Sensitivity and Specificity; Tyrosine | 2016 |
The prognostic value of FET PET at radiotherapy planning in newly diagnosed glioblastoma.
Topics: Adult; Aged; Brain Neoplasms; Female; Glioblastoma; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Tomography, X-Ray Computed; Tyrosine | 2017 |
Dynamic O-(2-[18F]fluoroethyl)-L-tyrosine PET imaging for the detection of checkpoint inhibitor-related pseudoprogression in melanoma brain metastases.
Topics: Brain Neoplasms; Humans; Melanoma; Neoplasm Metastasis; Positron-Emission Tomography; Radiopharmaceuticals; Tyrosine | 2016 |
Assessment of Tryptophan Uptake and Kinetics Using 1-(2-18F-Fluoroethyl)-l-Tryptophan and α-11C-Methyl-l-Tryptophan PET Imaging in Mice Implanted with Patient-Derived Brain Tumor Xenografts.
Topics: Animals; Biomarkers, Tumor; Brain Neoplasms; Carbon Radioisotopes; Cell Line, Tumor; Female; Humans; Metabolic Clearance Rate; Mice; Mice, Inbred BALB C; Mice, SCID; Molecular Imaging; Organ Specificity; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tissue Distribution; Tryptophan; Tyrosine | 2017 |
Suspected recurrence of brain metastases after focused high dose radiotherapy: can [
Topics: Brachytherapy; Brain Neoplasms; Female; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiosurgery; ROC Curve; Tyrosine | 2016 |
Radiation injury vs. recurrent brain metastasis: combining textural feature radiomics analysis and standard parameters may increase
Topics: Adolescent; Aged; Brain; Brain Neoplasms; Female; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Radiation Injuries; Radiometry; Tyrosine; Young Adult | 2017 |
Intra-lesional spatial correlation of static and dynamic FET-PET parameters with MRI-based cerebral blood volume in patients with untreated glioma.
Topics: Adult; Aged; Brain Neoplasms; Cerebral Angiography; Female; Glioma; Humans; Magnetic Resonance Angiography; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Tyrosine | 2017 |
Population Pharmacokinetic Approach Applied to Positron Emission Tomography: Computed Tomography for Tumor Tissue Identification in Patients with Glioma.
Topics: Aged; Brain Neoplasms; Female; Glioma; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Grading; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tyrosine | 2017 |
Unsupervised consensus cluster analysis of [18F]-fluoroethyl-L-tyrosine positron emission tomography identified textural features for the diagnosis of pseudoprogression in high-grade glioma.
Topics: Adult; Aged; Brain Neoplasms; Cluster Analysis; Disease Progression; Disease-Free Survival; Female; Glioma; Humans; Kaplan-Meier Estimate; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Grading; Pilot Projects; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Radiographic Image Interpretation, Computer-Assisted; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Time Factors; Treatment Outcome; Tyrosine; Unsupervised Machine Learning | 2017 |
Neurosarcoidosis on FET and FDG PET/CT.
Topics: Adult; Brain Neoplasms; Central Nervous System Diseases; False Positive Reactions; Fluorodeoxyglucose F18; Humans; Male; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Sarcoidosis; Tyrosine | 2017 |
Topics: Adolescent; Adult; Aged; Antineoplastic Agents, Immunological; Bevacizumab; Brain Neoplasms; Female; Glioma; Humans; Karnofsky Performance Status; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Recurrence, Local; Nonlinear Dynamics; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Re-Irradiation; Survival Analysis; Time Factors; Tyrosine; Young Adult | 2017 |
Patterns of failure for patients with glioblastoma following O-(2-[
Topics: Adult; Aged; Aged, 80 and over; Brain Neoplasms; Disease Progression; Female; Glioblastoma; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiology, Interventional; Radiopharmaceuticals; Radiotherapy, Image-Guided; Retrospective Studies; Treatment Failure; Tyrosine | 2017 |
Structural Optimization and Pharmacological Evaluation of Inhibitors Targeting Dual-Specificity Tyrosine Phosphorylation-Regulated Kinases (DYRK) and CDC-like kinases (CLK) in Glioblastoma.
Topics: Brain Neoplasms; Glioblastoma; Humans; Phosphorylation; Protein Kinases; Structure-Activity Relationship; Tyrosine | 2017 |
A biologically adapted dose-escalation approach, demonstrated for 18F-FET-PET in brain tumors.
Topics: Aged; Brain Neoplasms; Feasibility Studies; Female; Fluorine Radioisotopes; Glioblastoma; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Monte Carlo Method; Positron-Emission Tomography; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Tomography, X-Ray Computed; Tyrosine | 2008 |
Detection of tumour invasion into the pyramidal tract in glioma patients with sensorimotor deficits by correlation of (18)F-fluoroethyl-L: -tyrosine PET and magnetic resonance diffusion tensor imaging.
Topics: Adult; Aged; Brain; Brain Neoplasms; Contrast Media; Diffusion Magnetic Resonance Imaging; Female; Glioma; Humans; Male; Middle Aged; Movement Disorders; Neoplasm Invasiveness; Positron-Emission Tomography; Predictive Value of Tests; Pyramidal Tracts; Radiography; Sensation Disorders; Sensitivity and Specificity; Tyrosine | 2009 |
Association of F18-fluoro-ethyl-tyrosin uptake and 5-aminolevulinic acid-induced fluorescence in gliomas.
Topics: Adult; Aged; Aminolevulinic Acid; Biomarkers, Tumor; Brain Neoplasms; Female; Fluorescence; Glioma; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Middle Aged; Monitoring, Intraoperative; Neuronavigation; Neurosurgical Procedures; Positron-Emission Tomography; Predictive Value of Tests; Preoperative Care; Tyrosine | 2009 |
Comparative PET study using F-18 FET and F-18 FDG for the evaluation of patients with suspected brain tumour.
Topics: Adult; Aged; Brain; Brain Neoplasms; Diagnosis, Differential; Diagnostic Errors; Female; Fluorodeoxyglucose F18; Glioma; Humans; Lymphoma; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Prospective Studies; Radioisotopes; Reproducibility of Results; Sensitivity and Specificity; Tyrosine; Young Adult | 2010 |
[Fluoroethylthyrosine 18F PET in the detection of brain tumours].
Topics: Adult; Aged; Brain Neoplasms; Female; Fluorodeoxyglucose F18; Glioblastoma; Glioma; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Oligodendroglioma; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed; Tyrosine | 2010 |
Is there a place for FET PET in the initial evaluation of brain lesions with unknown significance?
Topics: Adult; Aged; Brain Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Radiography; Retrospective Studies; Tyrosine | 2010 |
Continuous low-dose temozolomide and celecoxib in recurrent glioblastoma.
Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Celecoxib; Cyclooxygenase 2 Inhibitors; Dacarbazine; Disease-Free Survival; DNA Modification Methylases; DNA Repair Enzymes; Female; Fluorine Radioisotopes; Follow-Up Studies; Glioblastoma; Humans; Male; Methylation; Middle Aged; Positron-Emission Tomography; Pyrazoles; Retrospective Studies; Sulfonamides; Temozolomide; Tumor Suppressor Proteins; Tyrosine | 2010 |
STAT3 tyrosine phosphorylation influences survival in glioblastoma.
Topics: Aged; Brain Neoplasms; Female; Glioblastoma; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Phosphorylation; Retrospective Studies; Signal Transduction; STAT3 Transcription Factor; Statistics, Nonparametric; Tyrosine | 2010 |
Comparison of F-18 FET-PET with F-18 FDG-PET for biopsy planning of non-contrast-enhancing gliomas.
Topics: Adult; Aged; Biopsy; Brain Neoplasms; Contrast Media; Female; Fluorodeoxyglucose F18; Glioma; Humans; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Recurrence; Treatment Outcome; Tyrosine | 2010 |
18F-FET-PET-based dose painting by numbers with protons.
Topics: Algorithms; Brain Neoplasms; Fluorine Radioisotopes; Glioblastoma; Humans; Linear Energy Transfer; Monte Carlo Method; Photons; Positron-Emission Tomography; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Intensity-Modulated; Tyrosine | 2010 |
Prognostic value of early [18F]fluoroethyltyrosine positron emission tomography after radiochemotherapy in glioblastoma multiforme.
Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Brain Neoplasms; Combined Modality Therapy; Dacarbazine; Disease-Free Survival; Female; Glioblastoma; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Temozolomide; Tyrosine | 2011 |
18Fluoroethyl-L-tyrosine-PET in long-term epilepsy associated glioneuronal tumors.
Topics: Adolescent; Adult; Brain Neoplasms; Child; Cohort Studies; Epilepsy; Female; Fluorine Radioisotopes; Glioma; Humans; Male; Middle Aged; Positron-Emission Tomography; Time Factors; Tyrosine; Young Adult | 2011 |
Common pathogenic pathways in melanoma and Parkinson disease.
Topics: Brain Neoplasms; Group VI Phospholipases A2; Humans; Levodopa; Melanoma; Neural Pathways; Parkinson Disease; Tyrosine | 2010 |
Hot spots in dynamic (18)FET-PET delineate malignant tumor parts within suspected WHO grade II gliomas.
Topics: Adolescent; Adult; Aged; Brain Neoplasms; DNA Methylation; Female; Glioma; Humans; Isocitrate Dehydrogenase; Magnetic Resonance Imaging; Male; Middle Aged; O(6)-Methylguanine-DNA Methyltransferase; Positron-Emission Tomography; Promoter Regions, Genetic; Prospective Studies; Radiopharmaceuticals; Tyrosine; World Health Organization; Young Adult | 2011 |
FET-PET for malignant glioma treatment planning.
Topics: Aged; Biopsy; Brain Neoplasms; Contrast Media; Female; Glioma; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Conformal; Retrospective Studies; Statistics, Nonparametric; Tomography, X-Ray Computed; Treatment Outcome; Tyrosine | 2011 |
A micro-PET/CT approach using O-(2-[18F]fluoroethyl)-L-tyrosine in an experimental animal model of F98 glioma for BNCT.
Topics: Animals; Boron Neutron Capture Therapy; Brain Neoplasms; Disease Models, Animal; Glioma; Multimodal Imaging; Positron-Emission Tomography; Rats; Tomography, X-Ray Computed; Tyrosine | 2011 |
Prognostic impact of postoperative, pre-irradiation (18)F-fluoroethyl-l-tyrosine uptake in glioblastoma patients treated with radiochemotherapy.
Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Brain Neoplasms; Combined Modality Therapy; Contrast Media; Cranial Irradiation; Dacarbazine; Dose Fractionation, Radiation; Female; Fluorine Radioisotopes; Gadolinium DTPA; Glioblastoma; Humans; Image Interpretation, Computer-Assisted; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm, Residual; Positron-Emission Tomography; Prognosis; Proportional Hazards Models; Prospective Studies; Survival Rate; Temozolomide; Treatment Outcome; Tumor Burden; Tyrosine | 2011 |
Finding the anaplastic focus in diffuse gliomas: the value of Gd-DTPA enhanced MRI, FET-PET, and intraoperative, ALA-derived tissue fluorescence.
Topics: Adult; Aminolevulinic Acid; Biopsy; Brain Neoplasms; Carcinoma; Contrast Media; Female; Fluorescence; Gadolinium DTPA; Glioma; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Monitoring, Intraoperative; Neurosurgical Procedures; Positron-Emission Tomography; Radiopharmaceuticals; Surgery, Computer-Assisted; Tyrosine | 2011 |
An interindividual comparison of O-(2-[18F]fluoroethyl)-L-tyrosine (FET)- and L-[methyl-11C]methionine (MET)-PET in patients with brain gliomas and metastases.
Topics: Brain; Brain Neoplasms; Glioma; Humans; Magnetic Resonance Imaging; Methionine; Neoplasm Recurrence, Local; Neoplasm, Residual; Positron-Emission Tomography; Prospective Studies; Sensitivity and Specificity; Time Factors; Tumor Burden; Tyrosine | 2011 |
STAT6 expression in glioblastoma promotes invasive growth.
Topics: Astrocytoma; Brain Neoplasms; Cell Line, Tumor; Cell Proliferation; Databases, Factual; Epidermal Growth Factor; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Silencing; Glioblastoma; Glioma; Humans; Neoplasm Invasiveness; Phosphorylation; RNA, Small Interfering; STAT6 Transcription Factor; Survival Analysis; Tyrosine | 2011 |
O-(2-18F-fluoroethyl)-L-tyrosine PET predicts failure of antiangiogenic treatment in patients with recurrent high-grade glioma.
Topics: Adult; Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Astrocytoma; Bevacizumab; Brain Neoplasms; Camptothecin; Combined Modality Therapy; Disease-Free Survival; Female; Glioma; Humans; Image Processing, Computer-Assisted; Irinotecan; Magnetic Resonance Imaging; Male; Middle Aged; Nervous System Diseases; Positron-Emission Tomography; Postoperative Complications; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Survival Analysis; Treatment Failure; Tyrosine; Ultrasonography | 2011 |
Classification of peritumoral fiber tract alterations in gliomas using metabolic and structural neuroimaging.
Topics: Adult; Aged; Brain Neoplasms; Diffusion Magnetic Resonance Imaging; Diffusion Tensor Imaging; Female; Fluorine Radioisotopes; Glioma; Humans; Magnetic Resonance Imaging; Male; Medical Oncology; Middle Aged; Nervous System Diseases; Neurology; Neurons; Positron-Emission Tomography; Prognosis; Tyrosine | 2011 |
Dynamic O-(2-[18F]fluoroethyl)-L-tyrosine (F-18 FET) PET for glioma grading: assessment of individual probability of malignancy.
Topics: Adolescent; Adult; Aged; Brain Neoplasms; Female; Glioma; Humans; Male; Middle Aged; Neoplasm Grading; Positron-Emission Tomography; Time Factors; Tyrosine; Young Adult | 2011 |
F-18 choline PET does not detect increased metabolism in F-18 fluoroethyltyrosine-negative low-grade gliomas.
Topics: Adult; Brain Neoplasms; Choline; False Negative Reactions; Female; Glioma; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tyrosine | 2012 |
Cost-effectiveness analysis of FET PET-guided target selection for the diagnosis of gliomas.
Topics: Biopsy; Brain Neoplasms; Cost-Benefit Analysis; Decision Trees; Glioma; Humans; Magnetic Resonance Imaging; Monte Carlo Method; Positron-Emission Tomography; Radiopharmaceuticals; Tyrosine | 2012 |
SPECT and PET imaging of meningiomas.
Topics: Acetic Acid; Adult; Ammonia; Brain Neoplasms; Carbon Radioisotopes; Choline; Female; Fluorodeoxyglucose F18; Humans; Male; Meningioma; Nitrogen Radioisotopes; Octreotide; Organometallic Compounds; Positron-Emission Tomography; Radiopharmaceuticals; Receptors, Somatostatin; Technetium; Thallium Radioisotopes; Tomography, Emission-Computed, Single-Photon; Tyrosine | 2012 |
Assessment of treatment response in patients with glioblastoma using O-(2-18F-fluoroethyl)-L-tyrosine PET in comparison to MRI.
Topics: Adult; Aged; Brain Neoplasms; Chemoradiotherapy; Contrast Media; Disease Progression; Disease-Free Survival; Female; Gadolinium; Glioblastoma; Humans; Kaplan-Meier Estimate; Magnetic Resonance Imaging; Male; Middle Aged; Neurosurgical Procedures; Positron-Emission Tomography; Prognosis; Proportional Hazards Models; Prospective Studies; Radiopharmaceuticals; Survival Analysis; Treatment Outcome; Tyrosine | 2012 |
FET-PET assessed recurrence pattern after radio-chemotherapy in newly diagnosed patients with glioblastoma is influenced by MGMT methylation status.
Topics: Adult; Aged; Aged, 80 and over; Brain Neoplasms; Chemoradiotherapy; DNA Methylation; DNA Modification Methylases; DNA Repair Enzymes; Female; Glioblastoma; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Tumor Suppressor Proteins; Tyrosine | 2012 |
Role of O-(2-(18)F-fluoroethyl)-L-tyrosine PET for differentiation of local recurrent brain metastasis from radiation necrosis.
Topics: Adolescent; Adult; Aged; Biological Transport; Brain Neoplasms; Diagnosis, Differential; Humans; Male; Middle Aged; Necrosis; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiation Injuries; ROC Curve; Tyrosine; Young Adult | 2012 |
Resistance to EGF receptor inhibitors in glioblastoma mediated by phosphorylation of the PTEN tumor suppressor at tyrosine 240.
Topics: Animals; Astrocytes; Brain Neoplasms; Cyclin-Dependent Kinase Inhibitor p16; Disease Models, Animal; Drug Resistance, Neoplasm; ErbB Receptors; Erlotinib Hydrochloride; Glioblastoma; Humans; Mice; Mice, Mutant Strains; Mice, Nude; Phosphorylation; Protein Kinase Inhibitors; PTEN Phosphohydrolase; Quinazolines; Signal Transduction; Transplantation, Heterologous; Tumor Cells, Cultured; Tyrosine | 2012 |
Re-irradiation in recurrent malignant glioma: prognostic value of [18F]FET-PET.
Topics: Adolescent; Adult; Aged; Brain Neoplasms; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Glioma; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Salvage Therapy; Survival Rate; Tyrosine; Young Adult | 2012 |
Diagnostic performance of 18F-FET PET in newly diagnosed cerebral lesions suggestive of glioma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Area Under Curve; Brain Neoplasms; Child; Child, Preschool; Female; Glioma; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Retrospective Studies; ROC Curve; Sensitivity and Specificity; Tyrosine | 2013 |
[18F]-fluoro-ethyl-L-tyrosine PET: a valuable diagnostic tool in neuro-oncology, but not all that glitters is glioma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Blood-Brain Barrier; Brain Neoplasms; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Glioma; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Grading; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tyrosine; Young Adult | 2013 |
Invasive behaviour of glioblastoma cell lines is associated with altered organisation of the cadherin-catenin adhesion system.
Topics: Adaptor Proteins, Signal Transducing; Adherens Junctions; Animals; Astrocytes; beta Catenin; Brain Neoplasms; Cadherins; Cell Adhesion; Cell Movement; Cells, Cultured; Cytoskeletal Proteins; Glioblastoma; Humans; Membrane Proteins; Microscopy, Confocal; Microscopy, Electron, Scanning; Neoplasm Invasiveness; Rats; Rats, Sprague-Dawley; Recombinant Fusion Proteins; Trans-Activators; Tumor Cells, Cultured; Tyrosine; Vesicular Transport Proteins | 2002 |
Brain tumors in mice are susceptible to blockade of epidermal growth factor receptor (EGFR) with the oral, specific, EGFR-tyrosine kinase inhibitor ZD1839 (iressa).
Topics: 3T3 Cells; Administration, Oral; Animals; Antineoplastic Agents; Blotting, Western; Brain Neoplasms; DNA Mutational Analysis; Enzyme Inhibitors; ErbB Receptors; Flow Cytometry; Gefitinib; Humans; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Phosphorylation; Protein-Tyrosine Kinases; Quinazolines; Signal Transduction; Time Factors; Tumor Cells, Cultured; Tyrosine | 2002 |
Whole-body distribution and dosimetry of O-(2-[18F]fluoroethyl)-L-tyrosine.
Topics: Adult; Brain Neoplasms; Female; Fluorine Radioisotopes; Humans; Male; Metabolic Clearance Rate; Middle Aged; Organ Specificity; Radiation Dosage; Radiometry; Radionuclide Imaging; Radiopharmaceuticals; Tissue Distribution; Tyrosine; Whole-Body Counting | 2003 |
Comparison of fluorotyrosines and methionine uptake in F98 rat gliomas.
Topics: Animals; Autoradiography; Brain; Brain Neoplasms; Cell Line, Tumor; Glioma; Male; Methionine; Radionuclide Imaging; Radiopharmaceuticals; Rats; Rats, Inbred F344; Tissue Distribution; Tissue Transplantation; Tyrosine | 2003 |
[Synthesis and preliminary studies of O-(2-[18F] fluoroethyl)-L-tyrosine as a positron emission tomography imaging agent].
Topics: Adult; Animals; Brain Neoplasms; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glioblastoma; Humans; Male; Mice; Middle Aged; Sarcoma 180; Tomography, Emission-Computed; Tyrosine | 2002 |
[ON THE DISTRIBUTION OF TYROSINE C-14 IN THE RAT BRAIN IN THE PRESENCE OF TRANSPLANTABLE BRAIN TUMORS AND ITS ACUTE PROLAPSE].
Topics: Autoradiography; Brain; Brain Neoplasms; Carbon Isotopes; Metabolism; Neoplasm Transplantation; Neoplasms, Experimental; Prolapse; Radiometry; Rats; Research; Tyrosine | 1964 |
Imatinib mesylate efficiently achieves therapeutic intratumor concentrations in vivo but has limited activity in a xenograft model of small cell lung cancer.
Topics: Animals; Antineoplastic Agents; Benzamides; Brain Neoplasms; Carcinoma, Small Cell; Cell Line, Tumor; Humans; Imatinib Mesylate; Immunoblotting; Immunoprecipitation; Ligands; Lung Neoplasms; Mice; Mice, Nude; Neoplasm Metastasis; Neoplasm Transplantation; NIH 3T3 Cells; Phosphorylation; Piperazines; Proto-Oncogene Proteins c-kit; Pyrimidines; Signal Transduction; Stem Cell Factor; Time Factors; Tyrosine | 2004 |
Tyrosine 734 of NCAM180 interferes with FGF receptor-dependent signaling implicated in neurite growth.
Topics: Animals; Brain Neoplasms; Cell Division; Cell Line; Chlorocebus aethiops; COS Cells; Humans; Neural Cell Adhesion Molecules; Neurites; Neuroblastoma; Rats; Receptors, Fibroblast Growth Factor; Recombinant Proteins; Signal Transduction; Structure-Activity Relationship; Tyrosine | 2004 |
Uptake of 18F-fluorocholine, 18F-fluoroethyl-L-tyrosine, and 18F-FDG in acute cerebral radiation injury in the rat: implications for separation of radiation necrosis from tumor recurrence.
Topics: Acute Disease; Animals; Brain; Brain Injuries; Brain Neoplasms; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Male; Necrosis; Neoplasm Recurrence, Local; Quaternary Ammonium Compounds; Radiation Injuries, Experimental; Radionuclide Imaging; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Tyrosine | 2004 |
O-(2-[18F]fluoroethyl)-L-tyrosine PET combined with MRI improves the diagnostic assessment of cerebral gliomas.
Topics: Adolescent; Adult; Aged; Biopsy; Brain Neoplasms; Child; Child, Preschool; Female; Fluorine Radioisotopes; Glioma; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Prospective Studies; Sensitivity and Specificity; Tyrosine | 2005 |
Multimodal metabolic imaging of cerebral gliomas: positron emission tomography with [18F]fluoroethyl-L-tyrosine and magnetic resonance spectroscopy.
Topics: Adolescent; Adult; Aged; Aspartic Acid; Biopsy; Brain; Brain Neoplasms; Child; Child, Preschool; Choline; Energy Metabolism; Female; Fluorine Radioisotopes; Glioma; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Middle Aged; Neuronavigation; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tyrosine | 2005 |
Evaluation of F-18-labeled amino acid derivatives and [18F]FDG as PET probes in a brain tumor-bearing animal model.
Topics: Animals; Boron Compounds; Brain; Brain Neoplasms; Cell Line, Tumor; Disease Models, Animal; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glioma; Glycopeptides; Metabolic Clearance Rate; Molecular Probe Techniques; Organ Specificity; Positron-Emission Tomography; Radiopharmaceuticals; Rats; Tissue Distribution; Tyrosine | 2005 |
Evaluation of new 18F-labeled amino acids for brain PET.
Topics: Animals; Autoradiography; Brain; Brain Chemistry; Brain Diseases; Brain Neoplasms; Glioma; Humans; Magnetic Resonance Imaging; Positron-Emission Tomography; Proline; Rats; Tyrosine | 2005 |
Tubulin nitration in human gliomas.
Topics: Aged; Astrocytes; Blotting, Western; Brain Neoplasms; Chromatography, High Pressure Liquid; Female; Glioma; Humans; Immunohistochemistry; Male; Middle Aged; Neurons; Proteomics; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Tubulin; Tyrosine | 2006 |
Differential effects of glial cell line-derived neurotrophic factor and neurturin in RET/GFRalpha1-expressing cells.
Topics: Animals; Brain Neoplasms; Cell Differentiation; Cell Line, Tumor; Cell Movement; Cell Survival; Glial Cell Line-Derived Neurotrophic Factor; Glial Cell Line-Derived Neurotrophic Factor Receptors; Immunoblotting; Ligands; Mitogen-Activated Protein Kinase 3; Neuroblastoma; Neurons; Neurturin; Phosphorylation; Proto-Oncogene Proteins c-ret; Rats; Reverse Transcriptase Polymerase Chain Reaction; RNA; Signal Transduction; Tyrosine | 2006 |
Uptake of 18F-fluorocholine, 18F-fluoro-ethyl-L: -tyrosine and 18F-fluoro-2-deoxyglucose in F98 gliomas in the rat.
Topics: Animals; Blood-Brain Barrier; Brain Injuries; Brain Neoplasms; Cell Line, Tumor; Choline; Fluorodeoxyglucose F18; Glioma; Male; Metabolic Clearance Rate; Radiation Injuries; Radionuclide Imaging; Radiopharmaceuticals; Rats; Rats, Inbred F344; Tyrosine | 2006 |
Syntheses of F-18 labeled fluoroalkyltyrosine derivatives and their biological evaluation in rat bearing 9L tumor.
Topics: Animals; Brain Neoplasms; Fluorine Radioisotopes; Glioma; Radiopharmaceuticals; Rats; Rats, Inbred F344; Tissue Embedding; Tyrosine | 2007 |
A novel low-molecular weight inhibitor of focal adhesion kinase, TAE226, inhibits glioma growth.
Topics: Annexin A5; Antineoplastic Agents; Brain Neoplasms; Cell Adhesion; Cell Line, Tumor; Cell Movement; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Enzyme Inhibitors; Focal Adhesion Protein-Tyrosine Kinases; Glioma; Humans; Neoplasm Invasiveness; Phosphorylation; Tyrosine | 2007 |
Preferred transport of O-(2-[18F]fluoroethyl)-D-tyrosine (D-FET) into the porcine brain.
Topics: Adult; Animals; Biological Transport; Blood-Brain Barrier; Brain; Brain Neoplasms; Contrast Media; Dihydroxyphenylalanine; Female; Fluorine Radioisotopes; Humans; Male; Middle Aged; Positron-Emission Tomography; Stereoisomerism; Swine; Tissue Distribution; Tyrosine | 2007 |
Uptake of 18F-Fluorocholine, 18F-FET, and 18F-FDG in C6 gliomas and correlation with 131I-SIP(L19), a marker of angiogenesis.
Topics: Animals; Antibodies; Brain Neoplasms; Cell Line, Tumor; Choline; Fibronectins; Glioma; Male; Neovascularization, Pathologic; Radiopharmaceuticals; Rats; Rats, Wistar; Recombinant Fusion Proteins; Tyrosine | 2007 |
Spatial heterogeneity of low-grade gliomas at the capillary level: a PET study on tumor blood flow and amino acid uptake.
Topics: Adult; Amino Acid Transport Systems; Brain Neoplasms; Capillaries; Cerebellum; Female; Fluorine Radioisotopes; Glioma; Humans; Male; Microcirculation; Middle Aged; Oxygen Isotopes; Oxygen Radioisotopes; Positron-Emission Tomography; Radiopharmaceuticals; Tyrosine; Water | 2007 |
Human cytomegalovirus induces cellular tyrosine kinase signaling and promotes glioma cell invasiveness.
Topics: Astrocytes; Brain Neoplasms; Cell Line; Cell Line, Tumor; Cell Movement; Cytomegalovirus; Cytomegalovirus Infections; ErbB Receptors; Fibroblasts; Focal Adhesion Kinase 1; Glioblastoma; Humans; Phosphatidylinositol 3-Kinases; Phosphorylation; Proto-Oncogene Proteins c-akt; Signal Transduction; Tyrosine | 2007 |
FET PET for the evaluation of untreated gliomas: correlation of FET uptake and uptake kinetics with tumour grading.
Topics: Adolescent; Adult; Aged; Brain Neoplasms; Female; Glioma; Humans; Image Interpretation, Computer-Assisted; Male; Metabolic Clearance Rate; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Statistics as Topic; Tyrosine | 2007 |
The positive predictive value of O-(2-[18F]fluoroethyl)-L-tyrosine (FET) PET in the diagnosis of a glioma recurrence after multimodal treatment.
Topics: Adult; Aged; Biopsy; Brain Neoplasms; Cell Proliferation; Combined Modality Therapy; Disease Progression; Female; Glioma; Humans; Ki-67 Antigen; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Stereotaxic Techniques; Tyrosine | 2008 |
[Improved diagnostics of cerebral gliomas using FET PET].
Topics: Brain Neoplasms; Diagnosis, Differential; Fluorine Radioisotopes; Germany; Glioma; Humans; Positron-Emission Tomography; Societies, Medical; Tyrosine | 2007 |
What is the value of emission tomography studies in patients with a primary glioblastoma multiforme treated by 192Ir brachytherapy?
Topics: Adult; Aged; Brachytherapy; Brain; Brain Neoplasms; Carbon Radioisotopes; Combined Modality Therapy; Cranial Irradiation; Diagnosis, Differential; Disease-Free Survival; Female; Follow-Up Studies; Glioblastoma; Humans; Iridium Radioisotopes; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Postoperative Complications; Radiation Injuries; Radiotherapy, Adjuvant; Reoperation; Sensitivity and Specificity; Thallium Radioisotopes; Tomography, Emission-Computed, Single-Photon; Tyrosine | 2008 |
Correlation of F-18-fluoro-ethyl-tyrosin uptake with vascular and cell density in non-contrast-enhancing gliomas.
Topics: Adult; Aged; Blood Vessels; Brain Neoplasms; Cell Count; Female; Fluorodeoxyglucose F18; Glioma; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Tyrosine | 2008 |
Brain tumors: L-[1-C-11]tyrosine PET for visualization and quantification of protein synthesis rate.
Topics: Adult; Aged; Brain Neoplasms; Carbon Radioisotopes; Female; Glioma; Humans; Lymphoma, Non-Hodgkin; Male; Meningioma; Methionine; Middle Aged; Neoplasm Metastasis; Neoplasm Proteins; Tomography, Emission-Computed; Tyrosine; Vasculitis | 1995 |
Tyrosine-iodination converts the delta-opioid peptide antagonist TIPP to an agonist.
Topics: Amino Acid Sequence; Analgesics; Animals; Brain Neoplasms; Chromatography, High Pressure Liquid; Chromatography, Thin Layer; Enkephalin, D-Penicillamine (2,5)-; Enkephalins; Humans; Iodine; Mice; Molecular Sequence Data; Molecular Weight; Narcotic Antagonists; Neuroblastoma; Oligopeptides; Receptors, Opioid, delta; Spectrometry, Mass, Fast Atom Bombardment; Tetrahydroisoquinolines; Tumor Cells, Cultured; Tyrosine | 1995 |
Increased intracellular cyclic AMP levels suppress the mitogenic responses of human astrocytoma cells to growth factors.
Topics: Astrocytoma; Blotting, Western; Brain Neoplasms; Bucladesine; Cell Division; Cyclic AMP; Glial Fibrillary Acidic Protein; Growth Substances; Humans; Immunohistochemistry; Mitogens; Phosphorylation; Receptor Protein-Tyrosine Kinases; Thymidine; Tumor Cells, Cultured; Tyrosine | 1995 |
In vivo protein synthesis rate determination in primary or recurrent brain tumors using L-[1-11C]-tyrosine and PET.
Topics: Adult; Brain; Brain Neoplasms; Carbon Radioisotopes; Female; Humans; Male; Middle Aged; Models, Biological; Protein Biosynthesis; Recurrence; Tomography, Emission-Computed; Tyrosine | 1995 |
Contribution of magnetic resonance spectroscopic imaging and L-[1-11C]tyrosine positron emission tomography to localization of cerebral gliomas for biopsy.
Topics: Adult; Astrocytoma; Biopsy; Brain Neoplasms; Carbon Radioisotopes; Craniotomy; Female; Frontal Lobe; Glioblastoma; Glioma; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Stereotaxic Techniques; Temporal Lobe; Tomography, Emission-Computed; Tyrosine | 1994 |
Proliferative activity in human brain tumors: comparison of histopathology and L-[1-(11)C]tyrosine PET.
Topics: Adolescent; Adult; Antibodies, Monoclonal; Antigens, Neoplasm; Brain Neoplasms; Cell Division; Female; Humans; Ki-67 Antigen; Male; Middle Aged; Neoplasm Proteins; Nucleolus Organizer Region; Silver Staining; Tomography, Emission-Computed; Tyrosine | 1997 |
Conjugate chemistry, iodination and cellular binding of mEGF-dextran-tyrosine: preclinical tests in preparation for clinical trials.
Topics: Animals; Antineoplastic Agents; Brain Neoplasms; Dextrans; Epidermal Growth Factor; ErbB Receptors; Glioma; Iodine Radioisotopes; Mice; Tumor Cells, Cultured; Tyrosine | 1998 |
Synthesis and radiopharmacology of O-(2-[18F]fluoroethyl)-L-tyrosine for tumor imaging.
Topics: Animals; Astrocytoma; Brain Neoplasms; Chromatography, High Pressure Liquid; Colonic Neoplasms; Female; Humans; Male; Mammary Neoplasms, Experimental; Mice; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Transplantation; Tissue Distribution; Tomography, Emission-Computed; Transplantation, Heterologous; Tyrosine | 1999 |
First gene involved in glioblastoma progression identified.
Topics: Brain Neoplasms; Cell Adhesion Molecules; Cell Division; Disease Progression; ErbB Receptors; Glioblastoma; Humans; Microfilament Proteins; Phosphorylation; Tensins; Tyrosine | 1999 |
Activation of stat3 and stat1 DNA binding and transcriptional activity in human brain tumour cell lines by gp130 cytokines.
Topics: beta-Galactosidase; Brain Neoplasms; Chloramphenicol O-Acetyltransferase; Ciliary Neurotrophic Factor; Cytokines; DNA-Binding Proteins; DNA, Neoplasm; Fluorescent Antibody Technique, Indirect; Growth Inhibitors; Humans; Interleukin-6; Leukemia Inhibitory Factor; Lymphokines; Oncostatin M; Peptides; Phosphorylation; Signal Transduction; STAT1 Transcription Factor; STAT3 Transcription Factor; Trans-Activators; Transfection; Tumor Cells, Cultured; Tyrosine | 2000 |
Tumor-derived p53 mutant C174Y is a gain-of-function mutant which activates the fos promoter and enhances colony formation.
Topics: Amino Acid Substitution; Animals; Antigens, Polyomavirus Transforming; Brain Neoplasms; Colony-Forming Units Assay; Cysteine; Genes, fos; Genes, p53; Genes, Reporter; Humans; Mutagenesis, Site-Directed; Osteosarcoma; Point Mutation; Promoter Regions, Genetic; Rats; Recombinant Proteins; Transcription, Genetic; Transcriptional Activation; Transfection; Tumor Cells, Cultured; Tumor Suppressor Protein p53; Tyrosine | 2000 |
DNA repair protein O6-alkylguanine-DNA alkyltransferase is phosphorylated by two distinct and novel protein kinases in human brain tumour cells.
Topics: Adenosine Triphosphate; Amino Acid Sequence; Animals; Brain Neoplasms; Calcium-Calmodulin-Dependent Protein Kinases; Casein Kinase II; Cations; Chromatography, Agarose; Cricetinae; Cyclic AMP-Dependent Protein Kinases; Dose-Response Relationship, Drug; Electrophoresis, Polyacrylamide Gel; Enzyme Inhibitors; Genistein; Guanosine Triphosphate; Humans; Magnesium; Manganese; Medulloblastoma; Mice; Molecular Sequence Data; O(6)-Methylguanine-DNA Methyltransferase; Phosphates; Phosphorylation; Protein Kinase C; Protein Processing, Post-Translational; Protein Serine-Threonine Kinases; Rats; Recombinant Proteins; Sequence Homology, Amino Acid; Serine; Threonine; Tumor Cells, Cultured; Tyrosine; Tyrphostins | 2000 |
Tryptophan and tyrosine catabolic pattern in neuropsychiatric disorders.
Topics: Adult; Biogenic Monoamines; Brain Diseases; Brain Neoplasms; Digoxin; Epilepsy, Generalized; Erythrocytes; Fatty Acids, Nonesterified; Female; Glioma; Glycine Agents; Humans; Hydroxymethylglutaryl CoA Reductases; Kynurenic Acid; Magnesium; Male; Microvascular Angina; Middle Aged; Morphine; Narcotics; Nicotine; Nicotinic Agonists; Parkinson Disease; Quinolinic Acid; Schizophrenia; Serum Albumin; Sodium-Potassium-Exchanging ATPase; Strychnine; Tryptophan; Tyrosine; Ubiquinone | 2000 |
Endogenous strychnine, nicotine, and morphine--description of hypo and hyper-strychninergic, nicotinergic and morphinergic state in relation to neuropsychiatric diseases.
Topics: Adult; Alkaloids; Brain Neoplasms; Chromatography, High Pressure Liquid; Erythrocyte Membrane; Glioma; Humans; Male; Mental Disorders; Middle Aged; Morphine; Neoplasm Proteins; Nervous System Diseases; Nicotine; Sodium-Potassium-Exchanging ATPase; Strychnine; Tryptophan; Tyrosine | 2000 |
Up-regulation of functionally impaired insulin-like growth factor-1 receptor in scrapie-infected neuroblastoma cells.
Topics: Animals; Binding Sites; Brain Neoplasms; Cell Division; Coculture Techniques; Dose-Response Relationship, Drug; Humans; Kinetics; Mice; Neuroblastoma; Phosphorylation; Precipitin Tests; Protein Binding; Receptor, IGF Type 1; Reverse Transcriptase Polymerase Chain Reaction; Scrapie; Time Factors; Tumor Cells, Cultured; Tyrosine; Up-Regulation | 2001 |
Histochemical investigations of thyrosine in normal and pathological glia cells.
Topics: Astrocytes; Brain; Brain Neoplasms; Cell Nucleus; Cytoplasm; Humans; Neuroglia; Tyrosine | 1977 |
Effects of EGF-dextran-tyrosine-131I conjugates on the clonogenic survival of cultured glioma cells.
Topics: Brain Neoplasms; Cell Survival; Culture Media; Dextrans; Drug Carriers; Epidermal Growth Factor; Glioma; Humans; Iodine Radioisotopes; Time Factors; Tumor Cells, Cultured; Tumor Stem Cell Assay; Tyrosine | 1992 |
Increased amino acid transport into brain tumors measured by PET of L-(2-18F)fluorotyrosine.
Topics: Adult; Aged; Blood-Brain Barrier; Brain Neoplasms; Deoxyglucose; Edetic Acid; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Tomography, Emission-Computed; Tyrosine | 1991 |
Somatostatin receptor imaging with 123I-Tyr3-Octreotide.
Topics: Autoradiography; Brain Neoplasms; Breast Neoplasms; Humans; Iodine Radioisotopes; Multiple Endocrine Neoplasia; Octreotide; Pancreatic Neoplasms; Radiography; Radionuclide Imaging; Receptors, Neurotransmitter; Receptors, Somatostatin; Somatostatin; Tyrosine | 1990 |
[The changes in noradrenaline content in CSF of patients under electroacupuncture].
Topics: Acupuncture Therapy; Adolescent; Adult; Anesthesia; Brain Neoplasms; Electric Stimulation Therapy; Humans; Norepinephrine; Parkinson Disease; Serotonin; Transcutaneous Electric Nerve Stimulation; Tyrosine | 1988 |
[Data towards the histochemical characteristics of brain tumors in rats].
Topics: Animals; Arachnoid; Astrocytoma; Brain Neoplasms; DNA; Ependymoma; Glioblastoma; Glioma; Hemangioendothelioma; Histidine; Neoplasms, Experimental; Oligodendroglioma; Protein Biosynthesis; Rats; RNA; Tryptophan; Tyrosine | 1966 |
Failure of enzyme inhibition therapy for malignant melanoma.
Topics: Adult; Brain Neoplasms; Dihydroxyphenylalanine; Dopamine; Enzyme Repression; Epinephrine; Humans; Male; Melanoma; Neoplasm Metastasis; Norepinephrine; Tyrosine | 1969 |